Contributors Gün + Partners

Gün + Partners was founded in 1986 and is one of the largest law firms in Turkey with 13 partners and over 70 lawyers. The firm is based in Istanbul and provides transactional, advisory, and dispute management services to local and international companies throughout Turkey and assists clients worldwide through its established network of correspondents and contacts.

The firm's core areas of expertise are corporate and commercial, dispute management, and intellectual property. It represents clients in numerous industry sectors with a particular focus on life sciences, insurance and reinsurance, energy, construction and real estate, logistics, technology, media and telecoms, automotive, FMCG, chemicals and the defence industries.


Key Contacts

Intellectual Property, Dispute Management, Life Sciences, Corporate and M&A, Competition, Finance
Data Protection and Privacy, Corporate and M&A, Life Sciences, Competition, Technology, Media and Telecom
Employment, Dispute Management, Business Crimes and Anti-Corruption
Intellectual Property, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution
Intellectual Property, Patent and Utility Models, Insurance and Reinsurance
Corporate and M&A, Life Sciences, Energy and Natural Resources, Insurance and Reinsurance, Construction and Real Estate
Intellectual Property, Trademarks and Designs, Anti-Counterfeiting, IP Prosecution, Copyrights
Intellectual Property, Patent and Utility Models, Life Sciences
Life Sciences, Intellectual Property, Patent and Utility Models, Competition
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution, Technology, Media and Telecom
Intellectual Property, Anti-Counterfeiting, Business Crimes and Anti-Corruption, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution, Life Sciences, Technology, Media and Telecom
Intellectual Property, Dispute Management, Life Sciences, Corporate and M&A, Competition, Finance
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution, Technology, Media and Telecom
Intellectual Property, Anti-Counterfeiting, Business Crimes and Anti-Corruption, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution, Life Sciences, Technology, Media and Telecom
Life Sciences, Intellectual Property, Patent and Utility Models, Competition
Intellectual Property, Patent and Utility Models, Life Sciences
Intellectual Property, Trademarks and Designs, Anti-Counterfeiting, IP Prosecution, Copyrights
Corporate and M&A, Life Sciences, Energy and Natural Resources, Insurance and Reinsurance, Construction and Real Estate
Intellectual Property, Patent and Utility Models, Insurance and Reinsurance
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution
Intellectual Property, Trademarks and Designs, Copyrights
Employment, Dispute Management, Business Crimes and Anti-Corruption
Data Protection and Privacy, Corporate and M&A, Life Sciences, Competition, Technology, Media and Telecom
Dispute Management, Employment, Business Crimes and Anti-Corruption, Insurance and Reinsurance, Administrative, Tax and Regulatory, Construction and Real Estate
Life Sciences, Intellectual Property, Trademarks and Designs, Data Protection and Privacy
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution, Anti-Counterfeiting, Technology, Media and Telecom
Intellectual Property, Trademarks and Designs, Copyrights, Anti-Counterfeiting, Dispute Management, Employment
Dispute Management, Intellectual Property, Anti-Counterfeiting, Data Protection and Privacy
Intellectual Property, Anti-Counterfeiting, Trademarks and Designs, IP Prosecution, Copyrights
Life Sciences, Intellectual Property, Patent and Utility Models
Intellectual Property, Patent and Utility Models, Life Sciences, Trademarks and Designs
Corporate and M&A, Data Protection and Privacy, Technology, Media and Telecom
Intellectual Property, Patent and Utility Models, Life Sciences, Trademarks and Designs
Corporate and M&A, Data Protection and Privacy, Business Crimes and Anti-Corruption, Competition, Technology, Media and Telecom
Patent and Utility Models, Intellectual Property, Life Sciences
Business Crimes and Anti-Corruption, Employment, Dispute Management, Data Protection & Privacy, Corporate & M&A
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution
Intellectual Property, Patent and Utility Models, Trademarks and Designs
Intellectual Property, Trademarks and Designs, Copyrights, Life Sciences, Employment
Intellectual Property, Trademarks and Designs, Anti-Counterfeiting, Copyrights, IP Prosecution
Corporate and M&A, Data Protection and Privacy
Intellectual Property, Anti-Counterfeiting, Trademarks and Designs
Employment, Dispute Management, Business Crimes and Anti-Corruption, Administrative, Tax and Regulatory
Technology, Media and Telecom, Intellectual Property, Trademarks and Designs, Copyrights
Life Sciences, Intellectual Property, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights, IP Prosecution
Technology, Media and Telecom, Intellectual Property, Copyrights, Trademarks and Designs
Corporate and M&A, Dispute Management, Employment
Intellectual Property, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights, Anti-Counterfeiting
Corporate and M&A, Data Protection and Privacy
Patents and Utility Models, Intellectual Property, Dispute Management, Life Sciences, Technology, Media and Telecom Corporate and M&A
Intellectual Property, Life Sciences, Corporate and M&A, Patents and Utility Models, Data Protection and Privacy, Employment, Dispute Management, Competition
Intellectual Property, Anti-Counterfeiting, Trademarks and Designs
Intellectual Property, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, IP Prosecution, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights
Intellectual Property, Trademarks and Designs, Copyrights, Employment

İlaç Endüstrisinde Yapay Zeka Destekli Patentler

Yeni bir reçeteli ilacın geliştirilmesi pahalı ve uzun bir süreçtir. Tufts İlaç Geliştirme Araştırma Merkezi’nin bir çalışmasına göre, bir ilacın piyasaya sürülmesinin tahmini maliyeti yaklaşık 2,558 milyar dolardır.

Gün + Partners
19.11.2024

Calendarization Process for the Market Authorization of Medicines

The Guidelines for the Calendarization Process of Medicinal Products for Human Use aims to regulate the process for the market authorization applications on medicinal products for human use filed with the Turkish Medicines and Medical Devices Agency.

Gün + Partners
30.10.2024

Turkish Court of Cassation’s Highlighting Decisions on Conceptual Similarity Evaluation

In the 1st paragraph of Article 6 of the Industrial Property Law no. 6769, which regulates the relative refusal grounds in trademark registration, the existence of a likelihood of confusion requires the condition of “identicalness or similarity” of the trademarks along with the similarity of the goods and/or services.

Gün + Partners
22.10.2024

Biyobenzer İlaçlar ve Patent Tecavüzü Karinesi

Jeneriklere karşı patent haklarının ileri sürülmesi için açılabilecek davaların öncesinde patent hakkı sahibi esasen karanlıkta ilerler. Çünkü özellikle jenerik ilacın kısa ürün bilgisinin henüz yayınlanmadığı veya patentin ihlal edilip edilmediğinin kısa ürün bilgisinde yer alan sınırlı bilgilerle anlaşılamadığı durumlarda ...

Gün + Partners
22.10.2024

Beşeri Tıbbi Ürünlerin Ve Özel Tıbbi Amaçlı Gıdaların Tanıtım Faaliyetleri Hakkında Yönetmelik Taslağı İkinci Kez Görüşe Açıldı

Türkiye İlaç ve Tıbbi Cihaz Kurumu, 2024 yılının ikinci çeyreğinde resmi internet sitesinde bir duyuru yayınlayarak Beşeri Tıbbi Ürünlerin ve Özel Tıbbi Amaçlı Gıdaların Tanıtım Faaliyetleri Hakkında Yönetmelik Taslağını dış görüşe sunmuştu.

Gün + Partners
21.10.2024

Second Round of Comments on Draft Regulation for Pharmaceutical Promotions

In the second quarter of 2024, the Turkish Medicines and Medical Devices Agency published an announcement on its website, opening the Draft Regulation on the Promotional Activities of Human Medicinal Products and Food for Special Medical Purposes for external comments.

Gün + Partners
15.10.2024

From Plant to Pill: Introducing Cannabis to the Pharma Industry

The Regulation on the Cultivation and Control of Cannabis for the Production of Active Pharmaceutical Ingredients prepared by the Ministry of Agriculture and Forestry was published and came into force upon being published in the Official Gazette numbered 32661 dated 13 September, 2024.

Gün + Partners
12.10.2024

Enforcement of Foreign Judgments 2025 in Turkey - Part 2

Turkish law does not recognise the concept of personal jurisdiction, and therefore the enforcing court will not conduct such an examination.

Gün + Partners
04.10.2024

Enforcement of Foreign Judgments 2025 in Turkey - Part 1

Except for multilateral treaties on family law, Türkiye is not a signatory to multilateral treaties for the reciprocal recognition and enforcement of foreign judgments.

Gün + Partners
04.10.2024

A Trade Mark or a Song? Turkish Court of Cassation Casts Some Light on This Distinction

Article 4 of the Law No. 6769 on Industrial Property indicates that sounds can be registered as trade marks if they are capable of being distinguishable for the goods or services of one undertaking from that of another: ...

Gün + Partners
30.09.2024

The Supervisory Power of the Re-Examination and Evaluation Board

It is observed that the supervisory power of the Re-examination and Evaluation Board, which is in charge of examining and finalizing appeals against the decisions taken by the Turkish Patent and Trademark Office regarding the registration of IP rights, is in the form of a review of expediency.

Gün + Partners
25.09.2024

Applying Presumption of Patent Infingement Against Biosimilars

Before filing lawsuits to assert patent rights against generics or biosimilars, the patent holder essentially operates in the dark.

Gün + Partners
24.09.2024

IP in Business Transactions 2024 in Turkey - Part 2

Security can be taken over all main IPRs, namely trade marks, patents, designs, and copyright. In practice, security is commonly taken over trade marks or patents. It is important to conduct detailed due diligence to determine the owner of the IPRs and whether any security has been taken over them.

Gün + Partners
19.09.2024

IP in Business Transactions 2024 in Turkey - Part 1

Basis for patent assignment. Under the Intellectual Property Law No. 6769 (IP Law), a patent can be assigned in whole. A patent cannot be assigned in part.

Gün + Partners
16.09.2024

Update on the Medical Devices Regulations in Turkey

The main framework for ensuring safety and compliance with the technical specifications is governed by the Law on Product Safety and Technical Specifications No. 7,223, which is an umbrella legislation covering all products intended to be placed on the market, supplied, or placed on the Turkish market.

Gün + Partners
12.09.2024

Guideline on Circumstances Requiring Reissue of a Marketing Authorization For a Licensed Pharmaceutical

The transfer of pharmaceutical marketing authorizations entails intricate and interconnected procedures.

Gün + Partners
03.09.2024

Implementation of Discovery of Evidence in Patent Law

One of the most important temporary protection measures regulated by Turkish law is the determination of evidence.

Gün + Partners
29.08.2024

Food Supplements

With the regulations published in the Official Gazette numbered 32169 and dated April 20, 2023, comprehensive amendments were made to the legislation on the use of health claims for food and food supplements and the use of nutrition claims.

Gün + Partners
27.08.2024

The Turkish Court of Cassation Reminds of the Significance of “Vested Rights” in Two Recent Decisions: Frigo V Frico

The concept of “vested rights” is notable in the Turkish trademark law, as it serves as a strong defense against potential refusal of a later mark because of the likelihood of confusion it may create against an earlier one.

Gün + Partners
26.08.2024

Interactions with HCPs, Transfer of Values and Payments

The Regulation on the Promotional Activities of Pharmaceutical Products for Human Use, dated July 3, 2015, regulates the promotional activities of medicinal products for human use.

Gün + Partners
22.08.2024

Named Patient Program

Named Patient Programs is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized but unavailable in the Turkish market for various reasons.

Gün + Partners
19.08.2024

Market Access – Alternative Reimbursement Models

In the presence of alternative reimbursement models such as payback, value-based, indication-based reimbursement, performance-based, etc., developed for drug reimbursement systems throughout the world, ...

Gün + Partners
15.08.2024

Pricing of Pharmaceuticals and the Fixed Exchange Rate

Due to the rapid increase in the current exchange rates, pharmaceutical prices have been one of the most controversial issues in Türkiye in 2023.

Gün + Partners
14.08.2024

Kullan ya da Kaybet! McDONALD’S, “BIG MAC” Markaları için Verdiği Savaşı Genel Mahkeme Önünde Kaybetti

İrlandalı hamburger zinciri Supermac Ltd., McDonalds’a ait olan “BIG MAC” markasına karşı 29, 30 ve 42. sınıflardaki mal ve hizmetler için kullanmama nedeniyle iptal talebinde bulunmuş ve Avrupa Birliği Fikri Mülkiyet Ofisi (“EUIPO”) İptal Birimi, “BIG MAC” markasının kullanımının ispat edilemediğini değerlendirerek 29, 30 ve 42. sınıflardaki tüm mal ve hizmetler için iptaline karar vermişti.

Gün + Partners
29.07.2024

İstanbul Bölge Adliye Mahkemesi 20. Hukuk Dairesi’nin 2021/1507 E 2023/1017 K. sayılı ve 2306.2023 Tarihli Kararı Kapsamında Marka Hakkına Tecavüz Davalarında Sessiz Kalma Yoluyla Hak Kaybı İlkesine Bakış

Sessiz kalma yoluyla hak kaybı ilkesi, marka hakkına tecavüz davaları bakımından düzenlenmiş bir kavram olmayıp, yıllar içerisinde doktrindeki görüşler ve yargı kararları ile hatları ve çerçevesi çizilen ve temelde 4721 sayılı Türk Medeni Kanunu madde 2 “dürüst davranma ilkesi” kapsamında anlaşılması gereken bir ilke olup, içinde “çelişkili davranma yasağı”, “kullanımı bilme/bilebilme”, “ciddi kullanım”, “hak düşürücü süre”, “bu sürenin başlangıcı” ve “süreyi kesen fiiller” gibi birçok kavramı barındırmaktadır[1].

Gün + Partners
17.07.2024

Guidelines on Packaging Information and Instructions for Use of Pharmaceuticals have been Updated

On June 11, 2024, the Turkish Medicines and Medical Devices Agency announced on its official website that the “Guideline on the Packaging Information and Instructions for Use of Medicinal Products for Human Use”, “Guideline on the Readability of the Packaging Information and Instructions for Use of Medicinal Products for Human Use” and “Guideline on Excipients in the Packaging Information and Instructions for Use of Medicinal Products for Human Use” have all been amended.

Gün + Partners
16.07.2024

Bağlantılı Hak Sahiplerinin Korunmasına İlişkin Yargıtay Hukuk Genel Kurulu Kararı

Kamuoyunda Kemal Sunal davası olarak da bilinen telif hukuku uyuşmazlığı, uzun yıllar süren çeşitli aşamalardan geçerek Yargıtay Hukuk Genel Kurulunun kararı ile nihai sonuca bağlandı.

Gün + Partners
03.07.2024

Filmlerin Kayıt Tescil Belgesi Alınması ile Tamamlanmış Sayılacağına İlişkin Yargıtay Kararı

Yargıtay 11. Hukuk Dairesi, taraflar arasında imzalanmış olan ortak film yapım sözleşmesinden doğan bir uyuşmazlık kapsamında; sözleşmede filmin ne zaman tamamlanmış sayılacağına ilişkin açık belirleme yapılmadığı durumda ...

Gün + Partners
02.07.2024

Corporate Governance and Directors' Duties in Turkey 2024 - Part 2

The principal duties of directors are: • To act prudently and diligently when conducting business and performing their duties and the business of the company. • To monitor and supervise the management and the business of the company to ensure that it complies with the principles of good faith and the interests of the company and its shareholders.

Gün + Partners
02.07.2024

Corporate Governance and Directors' Duties in Turkey 2024 - Part 1

The main forms of corporate entity used in Turkey are the: • Limited liability company (LLC). • Joint-stock company (JSC).

Gün + Partners
01.07.2024

Work Bearing the Characteristics of Its Author and the Signs of Work

The Law on Intellectual and Artistic Works ("LIAW"), which has been amended many times since its entry into force in 1952, still causes uncertainty and confusion in practice.

Gün + Partners
28.06.2024

A Current Plagiarism Debate: “Bit Palas vs. Sinek Sarayı”

“Plagiarism” is not clearly defined in Law No. 5846 on Intellectual and Artistic Works (“LIAW”). Plagiarism, which is defined by the Turkish Language Association as "pilferage," is used in the context of intellectual and artistic works law to mean "to present someone else’s work as your own, taking a piece from someone else’s work without citing the source."

Gün + Partners
26.06.2024

Court of Cassation Decision Linking the Completion of Films to Obtaining of the Film Registration Certificate

The 11th Civil Chamber of the Court of Cassation (“CoC”), in the context of a dispute arising out of a joint film production contract signed between the parties, agreed with the first instance court's finding that, ...

Gün + Partners
26.06.2024

Artificial Intelligence and Music Industry

One of the most striking developments in the music industry in 2023 was the release of the song “Heart on my Sleeves” by an anonymous user named “Ghostwriter” using the AI-created voices of world-famous singers Drake and the Weekend.

Gün + Partners
23.06.2024

Decision on the Protection of Neighboring Rights in Cinematographic Works

The copyright law dispute, also known by the public as the case of famous actor Kemal Sunal, was concluded with the decision of the Court of Cassation General Assembly of Civil Chambers after going through various stages for many years.

Gün + Partners
23.06.2024

What Will Be the Fate of the Guarantee Provided for the Preliminary Injunction Decision?

Is the Guarantee Provided for the Preliminary Injunction a Part of the Later Compensation Action Arising from the Unfair Preliminary Injunction?

Gün + Partners
14.06.2024

Turkish Legislation Offers Various Solutions to Tackle Trademark Squatting

Similar as in other countries, trademark squatting is also a common problem which foreign brands face in Türkiye.

Gün + Partners
12.06.2024

Discount Sale Ads and Loyalty Programs Under the Microscope

The Advertisement Board closely monitors the discount sales campaigns, which have become a tradition in e-commerce, held in November and known as "Legendary November Discounts", "Fabulous Friday Discounts", where discounts at various rates are announced for a large number of products.

Gün + Partners
06.06.2024

Advertisement Board’s Power to Block Access was Annulled

The Turkish Constitutional Court annulled paragraph 12 of Article 77 of the Consumer Protection Law, which granted the Advertisement Board the power to partially or entirely block access to websites containing unlawful advertising content.

Gün + Partners
06.06.2024

Beşeri Tıbbi Ürünlerin ve Özel Tıbbi Amaçlı Gıdaların Tanıtım Faaliyetleri Hakkında Yönetmelik Taslağı Yayımlandı

Türkiye İlaç ve Tıbbi Cihaz Kurumu, 28 Mayıs 2024 tarihinde Beşerî Tıbbi Ürünlerin ve Özel Tıbbı Amaçlı Gıdaların Tanıtım Faaliyetleri Hakkında Yönetmelik Taslağını resmi internet sitesinde yayımlamış olup Taslağa ilişkin görüşlerin 10 Haziran 2024 tarihi mesai bitimine kadar Kurumun resmi e-posta adresine iletilebileceği duyurulmuştur.

Gün + Partners
05.06.2024

A Draft Regulation on the Promotional Activities of Human Medicinal Products and Food For Special Medical Purposes Has Been Published

On May 28, 2024, the Turkish Medicines and Medical Devices Agency (“Agency”) published a Draft Regulation on the Promotional Activities of Human Medicinal Products and Food for Special Medical Purposes (“Draft”) on its official website and announced that opinions regarding the Draft can be delivered to the Agency’s official e-mail address until the end of working hours on June 10, 2024.

Gün + Partners
04.06.2024

Recent Changes in the Turkish Commercial Code

With the Law no. 7511 Amending the Turkish Commercial Code and Certain other Laws (the “Amendment Law”), which entered into force after being published in the Official Gazette dated 29.05.2024 numbered 32560, amendments are made primarily to the Turkish Commercial Code numbered 6102 (the “TCC”) and other certain laws.

Gün + Partners
03.06.2024

“a.tr” Yapısındaki Alan Adlarının Tahsisinde Süreler 7 Ağustos 2024’e Kadar Uzatıldı

Ülkemizde tahsisi halihazırda gerçekleştirilmekte olan “com.tr”, “org.tr” gibi alan adlarına ek olarak, “a.tr” yapısındaki alan adlarının da tahsisi de 14 Eylül 2023 tarihinden itibaren mümkün hale gelmiştir.

Gün + Partners
31.05.2024

Time Extension Granted: August 7, 2024 - Allocation of Domain Names in Structure of “a.tr”

In addition to domain names such as "com.tr" and "org.tr", which are already being allocated in Türkiye, allocation of domain names in the structure of "a.tr" has also become possible as of September 14, 2023.

Gün + Partners
31.05.2024

Corporate Governance in Türkiye 2024 - Part 3

The TCC allows a board of directors to consist of just one member (a real person or a legal entity) assigned by the articles of association or elected by the general assembly.

Gün + Partners
29.05.2024

Corporate Governance in Türkiye 2024 - Part 2

A share buy-back system that was already available for listed companies under capital markets legislation has been introduced by the TCC for joint stock companies in exceptional cases. The conditions for the buy-back are as follows (TCC, article 379):

Gün + Partners
28.05.2024

Corporate Governance in Türkiye 2024 - Part 1

The Turkish Commercial Code (TCC) dated 13 January 2011 (Law No. 6102) entered into force on 1 July 2012. The TCC has important objectives, such as ensuring transparency, adopting corporate governance standards and introducing internationally accepted auditing and reporting standards.

Gün + Partners
28.05.2024

Türkiye's Update: Key Changes in Named Patient Program

Pharmaceuticals that are not authorized in Türkiye or authorized but not available on the market shall be procured from abroad as per a special authorization and on a case by case basis (Named Patient Program-NPP).

Gün + Partners
22.05.2024

Kanunî Faiz Oranı, Gecikme Zammı ve Tecil Faizi Oranı Güncellendi

3095 Kanunî Faiz ve Temerrüt Faizine İlişkin Kanun’un (“3095 sayılı Kanun”) 1. maddesi uyarınca Türk Borçlar Kanunu ve Türk Ticaret Kanunu’na göre faiz ödenmesi gereken hallerde, miktarı sözleşme ile tespit edilmemişse bu ödeme yıllık %12 oranı üzerinden yapılır.

Gün + Partners
22.05.2024

Update on Legal Interest, Late Payment Fee and Deferment Interest Rates

According to Article 1 of the Law No. 3095 on Legal Interest and Default Interest (“Law No. 3095”), interests to be paid as per Turkish Code of Obligations and Turkish Commercial Code, shall be made at an annual rate of 12%, unless a different contractual rate is agreed.

Gün + Partners
22.05.2024

Latest Developments on Administrative Revocation of Trademarks!

While the relevant article regulating the transfer of authority to examine the requests for revocation of trademarks to the Turkish Patent and Trademark Office (“the Office”) was not yet entered into force and there were still a level of uncertainty concerning the procedure, the first development in this regard took place on October 23, 2023 when the Office published and opened the “Draft Regulation for Amendment of the Regulation on the Implementation of the Industrial Property Law” (“Draft Regulation”) for comments.

Gün + Partners
22.05.2024

Challenging and Enforcing Arbitration Awards: Türkiye - Part 3

Applying for interim measures under a foreign arbitral award before requesting recognition is controversial, and there are conflicting precedents. Recent precedents favour those applications.

Gün + Partners
21.05.2024

Challenging and Enforcing Arbitration Awards: Türkiye - Part 2

While domestic arbitral awards are directly enforceable under the CPL, arbitral awards within the scope of the IAL (where the seat is in Turkey and the matter has a foreign element) are enforced by obtaining a certificate of enforceability from the competent civil court of first instance.

Gün + Partners
20.05.2024

Challenging and Enforcing Arbitration Awards: Türkiye - Part 1

Article 14(A) of the International Arbitration Law (IAL) provides that an award must include: — the names, surnames, titles and addresses of the parties, their representatives and lawyers; — the legal grounds on which the award is based and, if there is a claim for compensation, the amount of compensation; — the place of arbitration and the date of the award;

Gün + Partners
20.05.2024

Riddle of Applicable Application Fee in Enforcing Foreign Judgments

Under Turkish law, the rules governing the collection of trial fees are regulated by the Law of Fees No. 492 (Law no. 492) and the applicable fees are under Tariff 1 of the Law no. 492. Article 4 of Law no. 492 also explicitly refers to Tariff 1 in terms of the fees applicable in the actions for enforcement of foreign judgments stating that the applicable fee will be determined according to the value, type and nature of the verdict.

Gün + Partners
07.05.2024

Reklamlarda Sosyal Sorumluluk Bilincinin Kapsamı Nasıl Değerlendirilir?

Reklam Kurulu, 9 Ocak 2024 tarihli toplantısında, Ticari Reklam ve Haksız Ticari Uygulamalar Yönetmeliği'nin reklamların ekonomik ve sosyal sorumluluk bilinci içinde hazırlanması gerektiğine ilişkin hükmüne ilişkin çarpıcı bir karar verdi.

Gün + Partners
06.05.2024

How to Evaluate Social Responsibility in Advertisements?

The Advertisement Board made a striking decision at its meeting on January 9, 2024.

Gün + Partners
05.05.2024

Bazı Menkul Satış Sözleşmelerinde Dövizle Ödeme Yasağı Kalktı

Türk Parası Kıymetini Koruma Hakkında 32 Sayılı Karara İlişkin Tebliğ’de (“Tebliğ”) 21 Nisan 2022 tarihinden itibaren geçerli olmak üzere yapılan değişiklikle birlikte, Türkiye'de yerleşik alıcılar için, taşıt sözleşmeleri hariç olmak üzere, menkul satış sözleşmelerinde, sözleşme kapsamındaki tüm ödemelerin döviz cinsinden veya dövize endeksli olarak yerine getirilmesi yönünde bir kararlaştırma yapılması durumunda, bu yükümlülüklerin Türk lirası cinsinden yerine getirilmesi gerektiği yönünde düzenleme yapılmıştı.

Gün + Partners
05.05.2024

Ban on Foreign Currency Payment in Certain Sale of Goods Contracts Lifted

With the amendment made to the Communiqué on the Decree numbered 32 Regarding the Protection of the Value of the Turkish Currency, effective as of April 21, 2022, for buyers residing in Türkiye, except for vehicle sale contracts, in the event that there is an agreement in the sale of goods contracts that all payments under the contract are to be made in foreign currency or indexed to foreign currency, it was regulated that these obligations must be fulfilled in Turkish lira.

Gün + Partners
05.05.2024

Bağımsız Denetime Tabi Şirketlerin Belirlenmesine İlişkin Son Değişiklikler

Bağımsız Denetime Tabi Şirketlerin Belirlenmesine Dair Kararda Değişiklik Yapılmasına İlişkin Karar, 6 Nisan 2024 tarihli Resmi Gazete’de yayımlandı.

Gün + Partners
01.05.2024

Recent Changes Regarding the Determination of Companies Subject to Independent Auditing

The Decision Amending the Decision on Determination of Companies Subject to Independent Auditing was published in the Official Gazette dated April 6, 2024.

Gün + Partners
26.04.2024

Türkiye İlaç ve Tıbbi Cihaz Kurumu Tıbbi Cihaz Sektör Belgesi Yayınlandı

Türkiye İlaç ve Tıbbi Cihaz Kurumu (“TİTCK”) tarafından tıbbi cihaz sektöründeki son yıllardaki gelişmeler ile birlikte pazarın mevcut durumunu ortaya koymak üzere hazırlanan Tıbbi Cihaz Sektör Belgesi 4 Nisan 2024 tarihinde TİTCK internet sitesinde yayınlanmıştır.

Gün + Partners
25.04.2024

Turkish Medicines and Medical Devices Agency Published the Industry Report on Medical Devices

On April 4, 2024, the Industry Report on Medical Devices, prepared by the Turkish Medicines and Medical Devices Agency ("Agency") to present the current state of the market together with recent developments in the medical device industry, was published on the Agency’s website.

Gün + Partners
22.04.2024

The Impact of Artificial Intelligence on Trademark Law

The impact of the spread of artificial intelligence (“AI”) technologies can be seen in many areas of law, including trademark law. The rapid development of AI technologies has given rise to the need to re-evaluate some of the basic practices and concepts of trademark law.

Gün + Partners
25.03.2024

Torba Kanun ile İlaç Mevzuatında Değişiklikler

1262 sayılı İspençiyari ve Tıbbi Müstahzarlar Kanunu ile 3359 sayılı Sağlık Hizmetleri Temel Kanunu’nundaki klinik araştırma hükümlerinde değişiklik yapılmasını öngören Sağlıkla İlgili Bazı Kanunlarda ve 663 Sayılı Kanun Hükmünde Kararnamede Değişiklik Yapılmasına Dair Kanun 1 Mart 2024 tarihli ve 32476 sayılı Resmi Gazete’de yayımlanmıştır.

Gün + Partners
22.03.2024

Omnibus Law Amends Pharmaceutical Legislation

On 1 March 2024, the Omnibus Law Amending Certain Laws and Decree Law No. 663 (the “Omnibus Law”), which amends certain provisions of the Law No. 1262 on Pharmaceuticals and Medical Preparations (the “Law No. 1262”) and the Fundamental Law on Healthcare Services No. 3359 (the “Law No. 3359”), was published in the Official Gazette numbered 32476.

Gün + Partners
21.03.2024

Jurisdictional Conflicts in Global FRAND Cases and the EU's WTO Complaint against China for Alleged Violation of TRIPs

Anti-suit injunctions ("ASI") issued by Chinese courts, which prevent parties of proceedings concerning standard-essential patents ("SEPs") from bringing proceedings against each other in different countries, have become one of the controversial issues in these proceedings, highlighting the "jurisdiction of the court".

Gün + Partners
20.03.2024

Named Patient Program in Turkey - 2024

Named Patient Program (“NPP”) is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized but unavailable in the Turkish market for various reasons.

Gün + Partners
18.03.2024

Turkish Court of Cassation’s Recent Approach to Public Policy in Enforcement and Setting-Aside of Foreign Arbitral Awards

In general terms, public policy is defined as a set of rules and principles ensuring a smooth conduct of public services, a state’s security and safety, and compliance of the relationship between individuals with the principles of peace and ethics[1]. Due to its conceptual nature and vulnerability to a turmoil of different interpretations, violation of public policy appears as one of the most prevalent counter arguments in enforcement and setting-aside proceedings of foreign arbitral awards. The legislation defines neither the concept of public policy nor the criteria on how it should apply.

Gün + Partners
13.03.2024

Combating Counterfeit and Smuggled Drugs

Foreign pharmaceutical trademarks, in principle, are registered in the name of the companies in the countries where they are established, and trademark protection procedures are managed by those companies. Although affiliates in Türkiye are not a party to trademark protection proceedings, since they become the marketing authorization holders of the drug, they are considered the relevant addressee of the Ministry of Health (“MoH”) in all transactions related to the product.

Gün + Partners
12.03.2024

The Relationship Between Virtual and Physical Goods and Services

The development of NFTs, artificial intelligence, and the metaverse has seen many individuals and legal entities start to include virtual goods and services within the scope of their trademarks. Discussions have been widely held about whether virtual goods and services are similar to physical goods and services and under which class these goods and services should be included in the Nice Classification, and the following developments have taken place in this regard.

Gün + Partners
07.03.2024

Trademark Filing History May Result in Finding of Bad Faith Under Turkish Law

It is widely accepted in the literature[1] and decisions of the Court of Cassation[2] (“CoC”) that an applicant's attempt to create a trademark portfolio by trying to register other well-known trademarks can be sufficient to constitute proof of bad faith.

Gün + Partners
06.03.2024

Overview of Turkish IP Protection: Navigating Challenges

Turkish IP legislation is mostly in compliance with EU legislation. With the adoption of IP Code No. 6769 back in 2017, it is fair to say that legislation regarding trademarks, designs and patents is in line with international norms and standards. While the legal framework provides a solid foundation for IP rights protection, practical obstacles persist, revealing the need for further improvements.

Gün + Partners
06.03.2024

Examination of Novelty of Designs in Türkiye

A decision of 29 March 2023 of the General Assembly of the Turkish Court of Cassation has clarified whether the examination of lawfulness of the Turkish Patent and Trademark Office’s decision on absolute novelty of a design is limited to the evidence submitted in the opposition process or whether ex officio examination can be conducted at any phase.

Gün + Partners
06.03.2024

The Turkish Riviera: A Strategic Battlefield in Combating Counterfeiters

With a coastline of almost 9.000 kilometres and more than 550 Blue Flag beaches, Turkey welcomes millions of domestic and foreign tourists each summer. The most popular area for holidays is the Turkish Riviera, encompassing the cities of Antalya and Muğla, in particular, and some parts of Aydın and Izmir, highlighting the main districts of Alanya, Antalya, Kemer, Fethiye, Marmaris, Bodrum, Kuşadası, and Çeşme, from the south to the west coast of Turkey.

Gün + Partners
22.02.2024

Impact of New Minimum Capital Amounts on Trade Registry Applications

With the Presidential Decree No. 7887 published in the Official Gazette dated November 25, 2023 and numbered 32380, the minimum capital amounts for joint stock and limited liability companies have been increased and accordingly, effective from January 1, 2024, the new minimum capital amounts have been determined as TRY 50,000 for limited liability companies, TRY 250,000 for joint stock companies and TRY 500,000 for joint stock companies that have adopted the registered capital system and are not publicly traded.

Gün + Partners
20.02.2024

Gıda ve Takviye Edici Gıdalardaki Sağlık Beyanı Hakkında TİTCK’dan Görüş Talep Edilebilecek

20 Nisan 2023 tarihli ve 32169 sayılı Resmî Gazetede Gıda ve Takviye Edici Gıdalarda Sağlık Beyanı Kullanımı Hakkında Yönetmelik (“Yönetmelik”) yürürlüğe girmiş ve takviye edici gıdaların etiketinde, tanıtımında veya reklamında sağlık beyanı kullanılabilmesi için Sağlık Bakanlığı’na bağlı Türkiye İlaç ve Tıbbi Cihaz Kurumu’ndan (“TİTCK”) izin alınması gerekliliği kaldırılmıştır.

Gün + Partners
18.02.2024

Agency Opinion on Health Claims in Food and Food Supplements Can Now Be Requested

The Regulation on the Use of Health Claims for Food and Food Supplements (“Regulation”) entered into force as of its publication on the Official Gazette dated 20 April 2023, and numbered 32169; and the requirement for obtaining approval from the Turkish Medicines and Medical Devices Agency ("Agency") under the Ministry of Health for the use of health claims in the labelling, promotion or advertisement of food supplements was abolished.

Gün + Partners
18.02.2024

Sinema Eserlerinde İktibas Serbestisi

5846 sayılı Fikir ve Sanat Eserleri Kanunu (“FSEK”) kapsamında açılan davalarda intihal bakımından önemli bir standart iktibas serbestisinin sınırlarıdır.  FSEK md. 35’e göre bir eserden iktibas yapılabilmesi için;

Gün + Partners
14.02.2024

Freedom of Quotation in Cinema Works

With respect to lawsuits filed in the scope of Law No. 5846 on Intellectual and Artistic Works (“FSEK") No. 5846, an important standard in terms of plagiarism is the limits of freedom of quotation.

Gün + Partners
13.02.2024

Türk Patent ve Marka Kurumu Nezdinde Markaların Kapsamındaki Mal ve Hizmetlerin Sınırlandırılması Uygulaması

Mal ve hizmet listesinin sınırlandırılması noktasında ulusal marka başvuruları ile uluslararası marka başvuruları bağlamında TÜRKPATENT uygulamasında farklılıklar olduğu gözlemlenmektedir. Uluslararası marka başvurularında marka sahipleri markalarının kapsamlarını daha sınırlı ve faaliyet alanlarına özgülemek suretiyle çok spesifik mal/hizmetler için başvurular yapmakta ve markalar bu hali ile TÜRKPATENT tarafından uygun görülmekte iken; yerel başvurularda gerek başvuru aşamasında gerek daha sonra yapılan sınırlandırma taleplerinin daha sıkı şartlara tabi tutularak ve daha dar yorumlandığı ve sıklıkla reddedildiği görülmektedir.

Gün + Partners
09.02.2024

What Copyright and Trademark Owners Should Know About the Approach to NFTs in the Republic of Türkiye

Non-fungible tokens (NFTs) have grown in popularity since first entering public consciousness in 2021. They are digital tokens and may represent unique—virtual or real-world—items including songs, artworks, GIFs, virtual game items, videos, and cartoons. NFTs are created using blockchain technology and primarily operate within Ethereum, a blockchain platform with automated (smart) transactions.

Gün + Partners
08.02.2024

Ecza Depoları Haricinde İlaç İhracatı Yapabileceklere İlişkin Koşullar Yayınlandı

Türkiye İlaç ve Tıbbi Cihaz Kurumu (“TİTCK”) tarafından Ecza Ticarethanesi Haricinde Yapılacak İhracat Koşullarına İlişkin Kılavuz (“Kılavuz”) 29 Aralık 2023 tarihinde yayınlanıp yürürlüğe girmiştir. Bu Kılavuz, kamu sağlığı korunarak, beşeri tıbbi ürünler ile özel tıbbi amaçlı gıda ürünlerinin ulusal ve uluslararası standartlara uygun olarak sevkiyat ve ihracat işlemlerinin gerçekleştirilmesi amacıyla hazırlanmıştır.

Gün + Partners
02.02.2024

“a.tr” Yapısındaki Alan Adlarının Tahsisi

Ülkemizde tahsisi halihazırda gerçekleştirilmekte olan “com.tr”, “org.tr” gibi alan adlarına ek olarak, “a.tr” yapısındaki alan adlarının da tahsisi de 14 Eylül 2023 tarihinden itibaren mümkün hale gelmiştir. “a.tr” yapısındaki alan adları, “.com”, “.net”, “.org” gibi uzantıları içermeyip doğrudan “.tr” ülke kodu uzantısına sahip alan adlarıdır.

Gün + Partners
31.01.2024

Allocation of Domain Names in Structure of “a.tr”

In addition to domain names such as "com.tr" and "org.tr", which are already being allocated in Türkiye, allocation of domain names in the structure of "a.tr" has also become possible as of September 14, 2023. Domain names in the structure of “a.tr” do not include extensions such as ".com", ".net", ".org", etc. but have a direct country code extension of ".tr".

Gün + Partners
31.01.2024

Kısmi İhtiyati Tedbir Kararı ile Orijinal İlacın Fiyat Düşüşünün Önlenmesi

Kanunlar ve uluslararası sözleşmeler ile kendilerine tanınmış patent haklarından yararlanmak isteyen ilaç patenti sahiplerinin, bu haklarından sağlıklı bir şekilde yararlanabilmeleri için doğru stratejiyi belirleyerek doğru zamanda doğru adımları atmaları büyük önem arz etmektedir. Zira Sınai Mülkiyet Kanunumuz ile ilaçların ruhsatlandırılması ve bunun için gerekli test ve deneyler de dâhil olmak üzere, patent konusu buluşu içeren deneme amaçlı fiiller patent hakkının istisnalarından bir tanesi olarak düzenlenmiştir.

Gün + Partners
29.01.2024

Markalar İçin İdari İptal Zamanı Geldi Çattı!

6769 sayılı Sınai Mülkiyet Kanunu’nun (“SMK”) 10.01.2017 tarihinde yürürlüğe girmesine kadar marka haklarına ilişkin olarak prosedürler, mülga 556 sayılı Markaların Korunması Hakkında Kanun Hükmünde Kararname (“KHK”) ile yürütülmekteydi. Marka hakkının sona ermesi hallerinden olan “iptal” müessesi ise her iki mevzuatta da yerini bulmakla beraber, SMK ile Türk Marka Hukukuna büyük bir yenilik getirilmiş olup, markalar hakkında iptal taleplerinin Türk Patent ve Marka Kurumu’ndan isteneceği düzenlenmiştir.

Gün + Partners
28.01.2024

New Exemption for Procurements of the State Supply Office

With the Law No. 7491 published in the Official Gazette dated 28 December 2023, an additional article 12 was added to the Public Procurement Law (the “Law”). Accordingly, a new exemption has been introduced for procurements of vehicles, vehicle renting, fuel, medicines, medical supplies and medical devices which are to be made by the General Directorate of State Supply Office (“DMO”) on behalf of the administrations.

Gün + Partners
28.01.2024

Conditions for Pharmaceutical Exporters Other than Pharmaceutical Warehouses is Published

On 29 December 2023, the Turkish Medicines and Medical Devices Agency (“Agency”) has published Guidelines on the Conditions for Pharmaceutical Export Made by Companies Other than Pharmaceutical Warehouses (the “Guidelines”). The Guidelines has been prepared in order to ensure the shipment and export of pharmaceutical products and dietary foods for special medical purpose in compliance with national and international standards, while protecting public health.

Gün + Partners
25.01.2024

Preventing Price Decreases of Original Pharmaceutical Products with Partial Preliminary Injunctions

Taking the right steps at the right time, with the most appropriate strategy, is significantly important for patent owners of pharmaceutical products wishing to benefit from the related rights granted to them by the laws and international conventions. Indeed, the Turkish Industrial Property Code regulates the exception of patent rights concerning experimental acts in regard to the product subject to the invention, as well as marketing authorization, and the necessary testing and experiments within its scope.

Gün + Partners
23.01.2024

It’s Time for Administrative Revocation of Trademarks!

Before the Industrial Property Law (IPL) no. 6769 entered into force on 10 January 2017, procedures related to trademark rights were governed by the former Decree Law no. 556 on the Protection of Trademarks (“Decree Law”). In cases where the rights on the trademark shall end, while the matter of “revocation” is established in both legislations, the introduction of the IPL brings a major change to Turkish Trademark Law in this regard: the IPL rules that requests for revocation of trademarks shall be filed before the Turkish Patent and Trademark Office (“the Office”).

Gün + Partners
23.01.2024

Guidelines on Medical Device Meetings Has Been Updated

On 4 January 2024, the Turkish Medicines and Medical Devices Agency (“Agency”) announced on its official website that the Guidelines on Scientific Meetings and Educational Events to be Held within the Scope of the Regulation on the Sales, Advertisement and Promotion of Medical Devices (“Guidelines”) has been updated.

Gün + Partners
19.01.2024

Tüketici Değerlendirmelerinde Yakın Takip Dönemi

İnternet üzerinde yapılan alışverişlerde tüketici değerlendirmeleri büyük önem taşıyor. Bu değerlendirmeler sayesinde tüketicilerin satın almayı değerlendirdiği ürün ya da hizmetin özellikleri ile kalitesi bakımından ve müşteriye gösterdiği özen bakımından bir kanaat oluşturması mümkün olabiliyor.

Gün + Partners
16.01.2024

Aggravated Scrutiny for Consumer Reviews

Consumer reviews are of great importance in online shopping as they enable consumers to form their opinion in terms of the features and quality of the products or services that they consider purchasing and the care and professionalism the sellers and providers present to consumers.

Gün + Partners
16.01.2024

İnternet Sitesi Açma ve Tescil Ettirme Yükümlülüğü

Türk Ticaret Kanunu’nun (“TTK”) bağımsız denetime tabi kıldığı anonim ve limited şirketler (bağımsız denetime tabi olan şirketlerin hangileri olduğu hakkında detaylı bilgi içeren makalemize ulaşmak için tıklayınız), yine aynı kanunun 1524. maddesi uyarınca, kuruluşlarının ticaret siciline tescili tarihinden veya bu yükümlülüğün yürürlüğe girmesi ile birlikte bu yükümlülük kapsamında girmeleri tarihinden itibaren 3 ay içinde bir internet sitesi açmak ve bu sitenin belirli bir bölümünü şirketçe kanunen yapılması gereken ilanların yayımlanmasına özgülemek zorunda kılınmıştır.

Gün + Partners
02.01.2024

Yurt Dışından İlaç Temini Usulünde Yapılan Son Değişiklikler

Türkiye’de ruhsatlandırılmamış veya ruhsatlı olmakla birlikte piyasada bulunmayan ilaçlara hastaların ihtiyaç duyduğu durumlarda; söz konusu ilaç, özel izinle yurt dışından ilaç temini olarak adlandırılan istisnai ithalat rejimi ile ülkemizdeki hastalara tedarik edilebilmektedir.

Gün + Partners
27.12.2023

Alternative Dispute Resolution System for Disputes Arising From ‘.tr’ Extended Domain Names in Türkiye

On 14 September 2022, TRABIS (‘.tr’ Network Information System) took over the management of ‘.tr’ extended domain names with the Regulation coming into force in Türkiye. According to the Regulation, domain names can be allocated as documented or undocumented. Undocumented allocation is carried out within the framework of the ‘first come, first served’ rule. This rule is applied to domain names with the most commonly used extensions such as ‘.com.tr’, ‘.org.tr’, ‘.net.tr’, etc. In the former legislation, it was necessary to prove (with documentation) that the owner of the domain name held another right (for example, trade mark, trade name, etc.) in order to obtain a domain name with the ‘.tr’ extension. Therefore, the Regulation has an innovative perspective in terms of previous practice in Türkiye.

Gün + Partners
25.12.2023

Recent Changes in the Named Patient Program

Pharmaceuticals not authorized in Turkey or authorized pharmaceuticals not available in the market, shall be procured from abroad as per a special authorization (named patient program) in cases where patients require such pharmaceuticals. While this exceptional import regime for pharmaceuticals was until recently regulated by the Medicines and Medical Devices Agency ("Agency") through guideline, the Regulation on Supply of Pharmaceuticals from Abroad ("Regulation") was published in the Official Gazette dated 3 February 2023 and numbered 32093. The Guideline on Supply of Pharmaceuticals from Abroad ("Guideline"), which contains the guiding provisions regarding the implementation of the Regulation, was once again updated on 22 September 2023, after being updated in April.

Gün + Partners
20.12.2023

Announcement on Products Not Evaluated as Medical Devices

On 30 October 2023, the Turkish Medicines and Medical Devices Agency (Agency) published an announcement (Turkish language) regarding products that are not considered within the definition of medical device or the scope of the legal framework.

Gün + Partners
11.12.2023

Turning the Turkish Tide on Rising Tactical Patent Invalidation Actions

Filing patent invalidation actions for tactical purposes such as jeopardising patent infringement actions of patent owners and gaining time by complicating the infringement proceedings has become a common strategy of infringers in recent years. This strategy may cause the patent owner to suffer due to the inability to use its patent properly during the limited protection period of 20 years, even if the invalidity claims do not have a solid basis and they are filed on a ‘try your luck’ basis.

Gün + Partners
07.12.2023

Anonim ve Limited Şirketler için Asgari Sermaye Tutarına ilişkin Mevzuat Güncellemesi

25 Kasım 2023 tarihli ve 32380 sayılı Resmi Gazete’de yayımlanan 7887 sayılı Cumhurbaşkanı Kararı ile anonim ve limited şirketler için asgari sermaye tutarının 5 kat artırılmasına karar verilmiştir.

Gün + Partners
27.11.2023

New Minimum Capital Requirements in Turkey: Impact on Joint Stock and LLCs

With the Presidential Decree numbered 7887 and published in the Official Gazette dated 25 November 2023 and numbered 32380, it has been decided to increase the minimum capital amount for joint stock and limited liability companies by 5 times.

Gün + Partners
27.11.2023

Turizm Amacıyla Konutların Kiralanmasına İlişkin Gelişmeler

7464 sayılı Konutların Turizm Amaçlı Kiralanmasına ve Bazı Kanunlarda Değişiklik Yapılmasına Dair Kanun (“Kanun”), 2 Kasım 2023 tarihinde Resmi Gazete’de yayınlanmıştır. Kanun konutların en fazla 100 gün süreyle kiralanmasına ilişkin şartları ve konutları turizm amacıyla kira verenlerin yükümlülüklerini detaylı şekilde düzenlemekte olup ilgili düzenlemeler 1 Ocak 2024 tarihinde yürürlüğe girecektir. Kanun koyucu tarafından son yıllarda dünyada ve ülkemizde ikincil konutların kısa süreli olarak kiralanması suretiyle turistik konutun yaygınlaşması ve bu hizmetlerin turizm sektöründe yeni bir alt kol haline geldiğini gözeterek turizm sektörünün tek elden ve kapsayıcı bir stratejiyle geliştirilmesi amacıyla konuyu düzenleme ihtiyacı duymuştur. Bu çerçevede, turizm amaçlı kiralanan konutların belgelendirilmesi, bunlardan elde edilen gelirlerin kayıt alınması, kayıt dışı kazancın engellenmesi, konutlarda kalacak kişilerin suç işlemesinin önüne geçilmesi için kimlik bildirme yükümlülüğünün uygulanabilmesi ve eşit bir rekabet ortamı yaratarak turizm sektöründeki tüm paydaşlara güvenilir bir yatırım ortamının oluşturulması hedeflenmektedir.

Gün + Partners
20.11.2023

Developments Regarding the Renting of Residential Places for Tourism Purposes

The Law No. 7464 on the Renting of Residential Places for Tourism Purposes and Amendments to Certain Laws (the "Law") was published in the Official Gazette on November 2, 2023. The Law regulates in detail the conditions for renting residential places up to 100 days and the obligations of those who rent their premises for short terms for tourism purposes. The relevant provisions of the Law will come into force on January 1, 2024.

Gün + Partners
16.11.2023

The Period of the Regulation Stating that Certain Loss Items will not be Considered in the Calculation of Capital Loss and Negative Equity is Extended

The Communiqué on the Procedures and Principles Regarding Implementation of Article 376 of the Turkish Commercial Code No. 6102 was amended on December 26, 2020, and it was regulated that certain loss items will not be considered in the calculations made in terms of capital loss or negative equity until January 1, 2023.

Gün + Partners
15.11.2023

Ticaret Unvanı Marka Hakkına Tecavüz Teşkil Eder Mi?

Önceki tarihli tescilli bir markanın, başka biri tarafından ticaret unvanı ve işletme adı olarak kullanılmasının ve tescilinin, ticaret unvanının ayrıca bir markasal kullanımının bulunmadığı durumlarda, marka hakkına tecavüz yaratıp yaratmadığı, hem 556 sayılı Kanun Hükmünde Kararname (“KHK”) hem de Sınai Mülkiyet Kanunu (”SMK”) döneminde bir çok uyuşmazlığa konu olmuş, mahkemeler yürürlükteki mevzuat hükümlerini ve somut uyuşmazlığın şartlarını dikkate alarak farklı yönlerde karar vermişlerdir.

Gün + Partners
06.11.2023

Can Trade Names Lead to Trademark Infringement in Turkey?

Whether a trade name or business name can create trademark infringement and unfair competition, particularly in cases where the trade name is not used as a trademark, is a controversial issue in Turkey. This issue has been subject to numerous disputes under both Decree Law No. 556 Pertaining to Protection of Trademarks and the Industrial Property Code (the IP Code). The courts, by considering the applicable provisions of the legislation in force, as well as the specific facts of each dispute, have rendered decisions on this topic.

Gün + Partners
01.11.2023

Minority Shareholders' Rights in Joint Stock Companies

In order to prevent the majority shareholders, who hold the superiority of capital and voting in the management of joint stock companies, from executing unfair and unjust acts against the minority shareholders and violating the rights of the minority shareholders, the legislator has granted some special rights to the minority shareholders and allowed them to protect their interests against the decisions taken with the influence of the majority.

Gün + Partners
16.10.2023

Eserin Sahibinin Hususiyetini Taşıması - Selvi Boylum Al Yazmalım

Yargıtay 11. Hukuk Dairesi’nin 24.05.2022 tarih ve 2020/8509 E. 2022/3996 K. sayılı kararı, hem eserin alametleri ve eserlerin sahibinin hususiyetini taşıması hususlarının incelenmesi açısından hem de Fikir ve Sanat Eserleri Kanunu’nda özellikle sinema eserlerine ilişkin olarak yapılan değişiklikler bakımından son derece yol gösterici ve açıklayıcı bir karar olmuştur.

Gün + Partners
12.10.2023

Kullanılmayan Markaların İptali Noktasında Yetki Devri İçin Geri Sayım Devam Ediyor!

10 Ocak 2024 itibariyle, markalara karşı sunulan iptal talepleri bakımından inceleme yetkisinin Türk Patent ve Marka Kurumu’na geçmesini düzenleyen kanun hükmü yürürlüğe girecek.

Gün + Partners
12.10.2023

Anonim Şirketlerde Azınlık Pay Sahiplerinin Hakları

Anonim şirketlerin yönetiminde, sermaye ve oy üstünlüğünü elinde bulunduran çoğunluk pay sahipleri tarafından, azınlık pay sahipleri aleyhine ve hakkaniyete aykırı tasarruflarda bulunulmasının ve azınlık pay sahiplerinin haklarının ihlal edilmesinin engellenmesi amacıyla, kanun koyucu azınlık pay sahiplerine özel bazı haklar tanımış ve çoğunluk etkisi ile alınan kararlara karşı menfaatlerinin korunmasına imkan tanımıştır. Böylelikle anonim şirketlerin yönetiminde söz sahibi olan çoğunluk pay sahipleri ile azınlık pay sahipleri arasındaki menfaat dengesi korunmaya çalışılmıştır.

Gün + Partners
09.10.2023

Guideline on Scientific Meetings on Medical Devices Updated

On 22 August 2023, the Turkish Medicines and Medical Devices Agency (Agency) announced an updated Guideline on Scientific Meetings and Educational Activities to be Held in Accordance with the Regulation on Sales, Advertising and Promotion of Medical Devices (Turkish language) (Guideline) on its official website. The Guideline replaced the previous version dated 15 November 2022.

Gün + Partners
06.10.2023

Healthcare Regulation 2024 in Turkey - Part 2

The Ministry of Health (MoH) is the main body in charge of health services in Türkiye. It regulates all healthcare institutions in the country, which includes patient care facilities such as hospitals, clinics and diagnostic centres and the practice of medical and other health professions. The Turkish Medicines and Medical Devices Agency (Agency) is a regulatory agency of the government that acts as the highest sanitary authority in terms of medical safety on medicines, health products, cosmetics and personal care products.

Gün + Partners
05.10.2023

Healthcare Regulation 2024 in Turkey - Part 1

Turkey's healthcare system, governed by the Fundamental Law on Healthcare Services No. 3359, falls under the Ministry of Health's purview. Social Security Institution (SSI) health insurance covers the active population, retirees, and dependents, while co-payments apply to certain services. The Health Services Pricing Commission regulates pricing, and the Regulation on Drug Reimbursement governs reimbursement. Licenses for private hospitals require Ministry of Health approval. Foreign companies cannot provide healthcare services. Competition law applies to private hospitals and clinics, subject to Turkish Competition Authority oversight.

Gün + Partners
02.10.2023

An In-Depth Analysis of Inventorship of AI and Türkiye’s Position

“In recent legal debates, the patentability of AI-generated inventions has been contentious. Historically, only humans were considered inventors, anchored in notions of personhood and intellect. Yet, in a bold move, South Africa and Australia's Federal Court recognised AI, specifically DABUS, as a potential inventor in 2021, defying conventional views. Proponents argue that this accommodates modern innovation trends, while sceptics raise concerns about ownership rights, potential inundation of trivial patents, and diminished human oversight. With patent laws varying globally, the landscape remains dynamic. As AI's role in R&D grows, more countries could re-evaluate their stances, reshaping the intellectual property (IP) sphere.”

Gün + Partners
27.09.2023

Reklam Kurulu Tarafından Tüketici Değerlendirmeleri Hakkında Kılavuz Yayınlandı

Reklam Kurulu tarafından hazırlanan “Tüketici Değerlendirmeleri Hakkında Kılavuz” (“Kılavuz”) Reklam Kurulu’nun 12.09.2023 tarihli ve 337 sayılı toplantısında ilke kararı olarak kabul edildi ve yayımlandı. Kılavuzun amacı; tüketici değerlendirmeleri ile ilgili temel ilkeler, bilgilendirme, kontrol süreci, aldatıcı kabul edilen durumlar ile yükümlülüklere ilişkin reklam veren, reklam ajansları, mecra kuruluşları ve reklamcılıkla ilgili tüm kişi, kurum ve kuruluşlara yol göstermek olarak belirlenmiştir.

Gün + Partners
25.09.2023

The Guideline on Consumer Reviews Has Been Published

The Guideline on Consumer Reviews (“Guideline”), enacted by the Advertisement Board at the meeting dated 12.09.2023 and numbered 337, has recently been published. The purpose of the Guideline is to inform advertisers, advertising agencies, media organizations and persons, institutions and organizations engaged in advertising activities on fundamental principles regarding consumer reviews, obligation of informing consumers and procedure for checking reviews before publication, along with commercial practices that are deemed misleading, and applicable responsibility and liability regime.

Gün + Partners
25.09.2023

Turkish Court of Cassation’s Comparison of Goods in Different Subclasses

During 2022, the 11th Civil Chamber of the Turkish Court of Cassation (the CoC) issued several decisions regarding trade marks covering goods in class 5. The CoC formed its evaluation on the likelihood of confusion by comparing the subclasses of class 5. The details of the decisions are provided below:

Gün + Partners
21.09.2023

Fikri Mülkiyet Hakları Perspektifinden Non-Fungible Token (NFT) Kavramı ve Türkiye’nin Pozisyonu

İlk NFT, Dapper Labs şirketinin yöneticilerinden Dete Shirley tarafından ERC-721 standardına uygun surette, 20 Eylül 2017 tarihinde oluşturulmuş olup[1] bu günün NFT’lerin doğum günü olduğu söylenebilir. Bu nedenle de 20 Eylül, Uluslararası NFT günü olarak kabul edilip kutlanmaktadır.

Gün + Partners
20.09.2023

Non-Fungible Tokens (NFTs) from Intellectual Property Law Perspective and Türkiye’s Position

September 20th is officially recognized as International NFT Day. On September 20th, 2017, the term NFT (non-fungible token) was officially coined by Dapper Labs Chief Technology Officer Dete Shirley in the form of the ERC-721 standard.[1] So, September 20th is the birthday of NFT.

Gün + Partners
19.09.2023

Yeşil Vaatler: Reklam Verenler Gelecekte Sözlerini Tutabilecekler Mi?

Günümüzde çevre duyarlılığının giderek artmasının etkisiyle; reklam verenler, ürünlerini ve hizmetlerini çevre dostu olarak tanıtarak ve tüketiciler nezdinde çevreye fayda sağladıkları algısını oluşturarak çevresel beyanları sıkça kullanmaktadır. Ancak gerçeğe aykırı ve tüketicileri yanıltıcı olabilecek, onların çevreye duyarlılık duygularını istismar edebilecek, rakipler nezdinde haksızlığa sebep olabilecek nitelikte reklamların önlenebilmesi için; çevresel beyanların kullanımına ilişkin hukuki sınırların ayrıntılı olarak düzenlenmesi gerekmektedir.

Gün + Partners
17.09.2023

Green or Simply Greenwashing?

Turkish law regulates environmental claims in advertising to prevent false and misleading claims. The Regulation on Commercial Advertisements and Unfair Commercial Practices and the Advertisement Board's Guideline for Environmental Claims in Advertising establish three principles for environmental claims: Advertisements must not abuse consumers' environmental sensitivity or potential lack of knowledge. Environmental signs in advertisements cannot be used in a deceptive manner. Environmental claims must be substantiated by scientific proof and technical demonstrations. Aspirational environmental benefit claims are subject to special scrutiny by the Advertisement Board. Advertisers can use aspirational environmental claims only if the claims are included in a publicly available and verifiable strategy plan.

Gün + Partners
17.09.2023

Council of State's Unification of Decisions on Appeals Filed by Intervening Parties

The Council of State of Turkey has recently ruled that intervening parties can appeal decisions individually, even if the principal party does not file an appeal. This is on condition that the intervening party's appeal is not against, or is not contradicting, the principal party's explanations or intent. The decision is binding for the courts and will allow intervening parties to have a greater say in the outcome of cases.

Gün + Partners
06.09.2023

Enforcement of Foreign Judgments 2024 in Turkey - Part 2

Turkey is not a signatory to the Hague Convention on the Recognition and Enforcement of Foreign Judgments in Civil and Commercial Matters. However, Turkey has bilateral treaties with many countries for the reciprocal recognition and enforcement of foreign judgments. The basic requirements for recognition of a foreign judgment in Turkey are that the foreign court must have respected the right of defense of the party against which enforcement is sought, the judgment must be final under the laws of the foreign country, and the judgment must not violate Turkish public policy.

Gün + Partners
04.09.2023

New Euro Fx Rate For Drug Prices

The Turkish government has increased the euro exchange rate used to price medicinal products by 30.5%. The new exchange rate is TRY14.0387, up from TRY10.7577. The increase is effective from July 24, 2023.

Gün + Partners
04.09.2023

Enforcement of Foreign Judgments 2024 in Turkey - Part 1

Turkey is not a signatory to the Hague Convention on the Recognition and Enforcement of Foreign Judgments in Civil and Commercial Matters. However, Turkey has bilateral treaties with many countries for the reciprocal recognition and enforcement of foreign judgments. The basic requirements for recognition of a foreign judgment in Turkey are that the foreign court must have respected the right of defense of the party against which enforcement is sought, the judgment must be final under the laws of the foreign country, and the judgment must not violate Turkish public policy.

Gün + Partners
04.09.2023

Joker’i Üzecek Karar Genel Mahkeme’den Geldi: BATMAN Gotham’ı Aydınlatmaya Devam Edecek!

BATMAN! Gotham’ın yılmaz koruyucusu, kötülerin düşmanı Batman bu sefer de marka savaşında karşımıza çıktı… Bu yazımız ile ele aldığımız Avrupa Birliği Adalet Divanı (“ABAD”) Genel Mahkemesi’nin (“Mahkeme”) 7 Haziran 2023 tarihli, T-735/21 sayılı, Aprile and Commerciale Italiana v EUIPO – DC Comics kararı[1], Batman’in ikonik yarasa şekil markasının tescil edilebilirlik şartlarını sağlayıp sağlamadığı irdelemiştir.

Gün + Partners
29.08.2023

Decision on the Pricing of Drugs Has Been Amended

The Presidential Decree 6932, issued on July 23, 2023, amends the Decision on Pricing of Medicinal Products for Human Use. Euro value in Turkish Lira for pricing increased by 30.5% to 14.0387 TRY in July 2023. Offsetting process won't apply during this change. Price thresholds are set at 48.41 TRY for price-protected products and 25.30 TRY for others. Previous increases up to 4 TRY aren't considered. The regulation, effective immediately, addresses the rapid exchange rate increase and ensures pharmaceutical availability.

Gün + Partners
23.08.2023

Tanınmış Markanın Kaynak Gösterme Fonksiyonuna Etkisi Üzerine Bir Karar İncelemesi

Avrupa Birliği Fikri Mülkiyet Ofisi'nin 01.02.2023 tarihli kararına göre, Google markası dünya çapında tanınmış kabul edilerek, "araçlar ve taşıtlar" kategorisinde yapılan marka başvurusu reddedilmiştir. Başvuru sahibi, Google'ın markasını kullanarak yapılan bu başvurunun reddedilmesine itiraz etmiştir. Ancak Genel Mahkeme, yapılan itirazı reddetmiştir. Mahkeme, görsel ve kavramsal benzerlikleri değerlendirirken "GC" ve "GOOGLE" kelimelerinin ilişkisini göz önünde bulundurmuş ve bu iki kelimenin birleşimiyle oluşan markada benzerlik olduğuna hükmetmiştir.

Gün + Partners
22.08.2023

İlaç Fiyatlandırılmasına Dair Karar’da Değişiklik

Beşerî Tıbbi Ürünlerin Fiyatlandırılmasına Dair Karar’da (“Karar”) Değişiklik Yapılması Hakkında 6932 sayılı Cumhurbaşkanı Kararı 23 Temmuz 2023 tarihli 32257 sayılı Resmi Gazete’de yayınlanmıştır. Karara eklenen geçici maddeler ile, Beşerî tıbbi ürünlerin fiyatlandırılmasında kullanılacak Türk lirası cinsinden 1 avro değerinin 2023 yılı temmuz ayında %30,5 oranında arttırılarak 14,0387 TL olması belirlenmiş, bu artış uygulanırken Karar’ın 3/3 maddesindeki mahsuplaşma işleminin uygulanmayacağı belirtilmiş,Kurdaki değişime paralel olarak Karar’da geçen fiyat baremleri güncellenerek, bu tutarlar fiyat korumalı ürünler için 48,41 TL, diğer ürünlerde 25,30 TL olarak belirlenmiştir. Dönemsel avro değeri güncellemesinde Karar’ın Geçici 7. maddesi kapsamında uygulanan 4 TL’ye kadar olan artışların dikkate alınmayacağı, güncelleme sonrasında 4 TL’ye kadar olan artışlar, TL değerinde değişiklik yapılmadan, ürünlerin depocuya satış fiyatları üzerine ekleneceği belirtilmiştir.Yeni düzenleme yayımı takip eden gün yürürlüğe girmiştir.

Gün + Partners
21.08.2023

Guidelines For Withdrawal and Recall of Medical Devices Published

The Guidelines regulate the procedures to be implemented to prevent unsafe and non-conforming medical devices from being placed on the market and the responsibilities of the relevant parties pursuant to Law No 7223 on Product Safety and Technical Regulations. In this regard, the Guidelines indicate the procedure on withdrawal and recall of medical devices and in vitro diagnostic devices from the market, and duties, authorities and responsibilities of the Agency and the medical devices companies.

Gün + Partners
17.08.2023

TÜRKPATENT’in Vulcan Selamı Kararı, Marka Yayıma İtirazlarında Telif Hakkı Sahipliği İddiasının İncelenme Kriterlerine Tutulan bir Işık…

6769 sayılı Sınai Mülkiyet Kanunu’nun (“SMK”) 6/6 maddesi uyarınca “Tescil başvurusu yapılan markanın başkasına ait kişi ismini, ticaret unvanını, fotoğrafını, telif hakkını veya herhangi bir fikri mülkiyet hakkını içermesi hâlinde hak sahibinin itirazı üzerine başvuru reddedilir”. Bu hükme dayanarak bir marka başvurusunun yayımına, telif hakkı sahipliğine dayanarak etmek mümkündür.

Gün + Partners
11.08.2023

Highly Logical: Turkish IP Office's Vulcan Salute Ruling Sets Final Frontier For Copyright Ownership Argument

According to Article 6/6 of the Turkish Industrial Property Code, “An application for registration of a trademark shall be refused upon the opposition of the right holder if it consists of a person’s name, trade name, photography, copyright or any other intellectual property right of another.” Based on this provision, it is possible to oppose an application relying upon the opponent’s other intellectual property rights ownership. On December 20 2022, the Re-Examination and Evaluation Board (the Higher Board) of the Turkish Patent and Trademark Office (the IP Office) rendered a decision including detailed explanations regarding the copyright ownership argument and set an excellent example of the IP Office’s criteria for accepting such an argument. Before discussing the decision, it should be noted that the Higher Board consists of three senior examiners and generally conducts a comprehensive and consistent examination. So, the Higher Board’s decisions are valuable as precedents in opposition proceedings.

Gün + Partners
10.08.2023

Sanal Moda

Günümüzde fiziksel evrene ek olarak sanal bir evrende de yaşamaya başlandığına şahit oluyoruz. Bu sanal evrenin gelişmesi ile birlikte kripto paralar, NFT ve metaverse gibi pek çok yeni kavram hayatımızda yer edinmiştir. Hemen hemen herkes gibi moda sektöründe faaliyet gösterenler de sanal evrende yaşanan gelişmeleri takip etmekte ve bu gelişmelere hızlıca uyum sağlamaya çalışmaktadır. Bununla birlikte, tıpkı fiziksel dünyada olduğu gibi sanal evrende de özellikle fikri mülkiyet haklarına ilişkin hak ihlalleri sebebiyle uyuşmazlıklar meydana gelmektedir. Hukukun, sanal evrendeki bu gelişmeler ve moda sektörü-sanal evren ilişkisine uyum sağlama sürecinin irdelenmesi için kaleme alınan bu makale, özellikle moda sektörü ve metaverse, NFT’ler ve fikri mülkiyet hakları arasındaki ilişkiye odaklanacaktır.

Gün + Partners
09.08.2023

Regulation on Licensing of Medicines Amended

The Regulation Amending the Regulation on Licensing of Human Medicinal Products was published in the Official Gazette on 27 May 2023. The amended provisions introduce a new reason for license suspension related to license transfer applications. To avoid suspension, license holders must provide proof of Good Manufacturing Practice compliance and a Production Site Authorisation Certificate for the active substance production site in Turkey. License holders must now notify the Medicines and Medical Devices Agency of license application rejections or withdrawals in other countries. The deadline for submitting notified body opinions or CE certificates for medicinal products with integrated medical devices is extended to 31 December 2028.

Gün + Partners
06.08.2023

Regulation on Technical Services For Medical Devices Published

On 26 May 2023, the Turkish Medicines and Medical Devices Agency (Agency) published the Regulation on Technical Services for Medical Devices Used for Provision of Healthcare Services (Turkish language) (Regulation) in the Official Gazette numbered 32202. The Regulation has been prepared by the Agency to regulate the qualifications, authorisation, supervision and training of technical services that will support activities such as installation, updates, upgrades, modification, maintenance or repair of medical devices used in healthcare services. It will also regulate the qualifications and training of the relevant personnel working in these technical services and determine the obligations of technical services and healthcare service providers.

Gün + Partners
02.08.2023

Yargıtay’a Göre Kötü Niyetin İspatı Mümkün Mü?

Fikri ve Sınai Haklar Hukuk Mahkemesi'ndeki bir davada, ticaret unvanının temel unsurunu oluşturan davacı markanın aynısı olan bir markaya karşı hükümsüzlük davası kabul edildi. Davalının aynı markayı tesadüfen yaratma ihtimali reddedildi ve kötü niyeti kanıtlandı. Yargıtay, önceki kararlarını çiğneyerek kötü niyetin tek başına benzer marka tesciliyle ispatlanamayacağına dair karar verdi. Bu karar, kötü niyetli tescillerin önünü açabilir ve marka hukukunun temel prensiplerine aykırıdır. Yerel Mahkeme ve Bölge Adliye Mahkemesi'nin değerlendirmeleri, Yargıtay tarafından haklı bulunmuştu. Ancak Yargıtay'ın bu kararı, beklenmedik ve çelişen bir nitelik taşıyor.

Gün + Partners
29.07.2023

Kısmi Zafer, Gerçek Bir Zafer Midir?

Ankara Bölge Adliye Mahkemesi (BAM), Türk Patent ve Marka Kurumu (TÜRKPATENT) Yeniden İnceleme ve Değerlendirme Kurulu kararının iptaline ilişkin iki uyuşmazlıkta yapılan yayıma itiraz süreçlerine ilişkin kararlar verdi. Kararlarda, itiraz gerekçelerinden birinin reddine rağmen, YİDK'ya başvurulmamasının Fikri ve Sınai Haklar Hukuk Mahkemesi'nce dikkate alınmaması gerektiği belirtildi. BAM, TÜRKPATENT'in uygulamasının farklı olabileceğini ifade etti ve itiraz sahiplerinin reddedilen gerekçeleri YİDK'ya taşımadığı durumda dikkate alınmayabileceğini açıkladı. Bu yaklaşım, iş yükünü artırabilir ve marka hakkının öne sürülebilirliği ile idari kararların tutarlılığı açısından sorunlar doğurabilir.

Gün + Partners
24.07.2023

Is Partial Victory a Real Victory? - July 2023

Upon reviewing decisions of the Ankara Regional Court of Appeal in the 1st and 2nd cases, it is concluded that if an argument is rejected during opposition proceedings before the IP Office and no appeal is filed against the non-acceptance of the argument before the Higher Board, the IP Court should not consider that argument for cancellation claims. The RCA maintains its stance that an argument cannot be raised for cancellation if no appeal was filed. It is advised to appeal if an argument is crucial for a cancellation claim or total victory. The IP Office's implementation is contradictory, accepting one argument but rejecting appeals against other arguments. Changes in the IP Office's implementation are expected.

Gün + Partners
19.07.2023

Çevrim İçi Kullanımda Basın Hakları

Dijital teknolojiler, yaratıcı içeriğin üretilme, dağıtılma ve erişilme şeklini dönüştürmeye devam etmekte olup bu durumdan en çok etkilenen kesimlerden biri de basılı yayın sektörüdür. Nitekim AB Komisyonu’nun 2021 yılında yapmış olduğu anket sonuçları[1], AB’deki 16-74 yaş aralığındaki internet kullanıcılarının %72'sinin çevrim içi haber siteleri, çevrim içi gazeteler ve dergileri takip ettiğini ortaya koymuştur.

Gün + Partners
11.07.2023

Türkiye'de Sinema Eserlerinin Korunması

2001 tarihli FSEK metni, Türkiye'nin taraf olduğu uluslararası sözleşmelere taraf olan ülkelerde üretilmiş ve 03 Mart 2001 tarihinden önce kamu malı olmayan tüm eserleri kapsadığından; sinema eserlerinin koruma süresine ilişkin 2001 tarihli metinle getirilen yeni esaslar uygulanmalıdır. Buna göre; 12.06.1995 tarihinden önce yaratılan eserler bakımından eser sahibi Yapımcı olarak kabul edilmeli ve (i) Yapımcı gerçek kişi ise koruma, Yapımcının yaşamı boyunca ve ölüm tarihinden itibaren 70 yıl olmalıdır (ii) Yapımcının tüzel kişi olması halinde ise, eserin kamuya arzından itibaren 70 yıl olarak korunması gerekmektedir.

Gün + Partners
10.07.2023

Tefhimden İtibaren Kanun Yoluna Başvuru Hakkında Anayasa Mahkemesi’nin Güncel Kararı

Gerekçeli kararın taraflara tebliğinden itibaren istinaf ve temyiz başvuru sürelerinin başladığı kanunlarla düzenlenmiştir. Ancak uygulamada, taraflara gerekçeli kararın tebliğ edilmediği durumlarda süre tutum dilekçesi sunulması gerekmektedir. Anayasa Mahkemesi, bu uygulamanın mahkemeye erişim hakkını engellediğini belirterek, sürenin gerekçeli kararın tebliğiyle başlaması gerektiğine karar vermiştir. Ancak bu kararın uygulamada değişmeyebileceği düşünülmektedir.

Gün + Partners
08.07.2023

Türk Hukukunda Avrupa Patentlerinin Korunması ve Tecavüz Durumunda Zararın Tazmini

"Avrupa Patentlerinin Türkiye'de Verilmesi ile İlgili Yönetmelik"e göre, Türkiye'de seçilen bir Avrupa patent başvurusu, EPO tarafından başvuru numarası verildikten sonra ulusal bir Türk patent başvurusu olarak kabul edilir. Ancak Türk Patent Ofisi'nin başvuruyu yayınlama süresi belirsizdir. Bu nedenle patent sahipleri genellikle Türkçe çevirinin yayınlanma aşamasını atlayarak başvuruyu EPO tescilinden sonra Türk Patent Ofisi'ne kaydettirmektedir. Yönetmelik ayrıca, tazminat talebinde bulunabilmek için Türkçe çevirinin yayınlanmış veya üçüncü taraflara bildirilmiş olması gerektiğini düzenlemektedir. Bu nedenle, patent başvurusu sahipleri Türkçe çevirinin mümkün olan en kısa sürede yayınlanmasını veya üçüncü taraflara bildirilmesini sağlamalıdır.

Gün + Partners
05.07.2023

PTO Issues Important Decision on Distinctiveness of Trademarks Consisting of Device Element and Descriptive Words

The Turkish Patent and Trademark Office's Re-examination and Evaluation Board (REEB) overturned the Trademarks Directorate's refusal of a mark application. The application included a device element followed by descriptive words, "Clinical Trial Center." The REEB determined that the device element provided distinctiveness to the mark, and the descriptive phrase was not the main element. The decision emphasized the importance of the size and position of elements in composite trademarks. It clarified that registration wouldn't grant exclusive rights to the descriptive word element.

Gün + Partners
04.07.2023

Gıda ve Takviye Edici Gıdalarda Sağlık Beyanı ve Beslenme Beyanı Kullanımı

20 Nisan 2023 tarihli ve 32169 sayılı Resmi Gazetede yayımlanan düzenlemelerle gıda ve takviye edici gıdalarda sağlık beyanının kullanımına ilişkin mevzuat ile beslenme beyanlarına ilişkin mevzuatta kapsamlı değişiklikler yapıldı. Söz konusu değişikliklerle birlikte; beslenme beyanlarına ilişkin yeni düzenleme olan Türk Gıda Kodeksi Beslenme Beyanları Yönetmeliği ile gıda ve takviye edici gıdalarda sağlık beyanlarına ilişkin yeni düzenleme olan Gıda ve Takviye Edici Gıdalarda Sağlık Beyanı Kullanımı Hakkında Yönetmelik (“Yönetmelik”) yürürlüğe girmiştir ve 20 Nisan 2023 tarihine kadar sağlık beyanları ve beslenme beyanlarına ilişkin düzenlemelerin birlikte yer aldığı Türk Gıda Kodeksi Beslenme ve Sağlık Beyanları Yönetmeliği yürürlükten kaldırılmıştır.

Gün + Partners
25.06.2023

New Regulations on Nutrition and Health Claims for Food and Food Supplements / June 2023

The Turkish Food Codex Regulation on Nutrition Claims and the Regulation on Health Claims for Food and Food Supplements have replaced the previous regulations. The Turkish Pharmaceuticals and Medical Devices Authority has drafted the Guideline on Health Claims for Food and Food Supplements. Under the new system, health claims listed in the Guideline can be used without official permission, provided they comply with the Regulation and Guideline. The Authority has monitoring and supervising powers. Companies must ensure compliance and provide requested information.

Gün + Partners
22.06.2023

The Guide to Challenging and Enforcing Arbitration Awards in Turkey - Third Edition / Part 3

Procedure for interim measures against assets in Turkey: A creditor seeking enforcement can obtain a provisional attachment order by establishing that receivables are matured and unsecured, and there is a present danger that the debtor lacks sufficient assets. The attachment proceedings must be conducted before the competent court at the debtor's residence. Immovable, movable, and intangible property can be attached through the provisions of the Execution and Bankruptcy Law. Bank accounts held by banks in Turkey can be attached, while those located abroad are not subject to attachment. Sovereign immunity may apply to assets owned by foreign states, with exceptions for assets used for commercial purposes. Waiver of immunity is possible through an agreement. Piercing the corporate veil is exceptional, requiring evidence of fraud or misconduct.

Gün + Partners
22.06.2023

Temsil İç Yönergelerinde Temsil Yetkisinin Kapsam ve Sınırlarına İlişkin Uygulama Değişikliği

İstanbul Ticaret Sicil Müdürlüğü, temsil iç yönergeleri hazırlanırken temsil yetkisinin kapsam ve sınırlarına ilişkin olarak dikkat edilmesi gereken hususlara ilişkin internet sitesinde bir duyuru yayınlamıştır. Şirketin yönetim organının haiz olduğu yetkilerin bir iç yönerge kapsamında, sınırlı yetkili temsilcilere devredildiği anonim ve limited şirketlerde, mevcut iç yönergelerin yeniden gözden geçirilerek, duyuru kapsamında uygulama değişikliğine ilişkin belirtilen hususlar bakımından uygunluğunun ele alınması gerekliliği doğmuştur.

Gün + Partners
21.06.2023

Registry Practice Change Relating to Internal Directives for Representation of Companies

Istanbul Trade Registry (the “Registry”) published an announcement on its website regarding the issues to be considered regarding the scope and limits of representation authorization when preparing internal directives on representation. In joint stock and limited liability companies where the powers of the management body of the company are delegated to limited authorized representatives within the scope of an internal directive, it has become necessary to review the existing internal directives and to address their compliance with the issues stated in the announcement regarding the change of practice.

Gün + Partners
21.06.2023

The Guide to Challenging and Enforcing Arbitration Awards in Turkey - Third Edition / Part 2

To have jurisdiction over an application for recognition and enforcement, the court must be located where the parties agreed or where the defendant resides. If the defendant is not in Turkey, jurisdiction lies where the defendant's attachable assets are located. The applicant must prove the assets are within the court's jurisdiction. The application should include the original or certified copies of the arbitration agreement and arbitral award, along with certified translations. The proceedings are adversarial, with a written phase followed by an oral phase. The court's decision can be appealed. The court can adjourn proceedings if annulment proceedings are ongoing. Assets that can be attached include movable and immovable assets, but certain exemptions apply. Interim measures can be obtained before or during arbitration proceedings.

Gün + Partners
19.06.2023

The Guide to Challenging and Enforcing Arbitration Awards in Turkey - Third Edition / Part 1

Under Turkish law, an award must include specific information such as the names, addresses, and representatives of the parties involved, the legal basis of the award, the place and date of arbitration, and a notice regarding the possibility of challenging the award. Parties can request corrections or interpretations of an award within a certain time frame. The only recourse available is to file an action to set aside the award. Setting-aside actions must be filed within 30 days of the award's service date. Turkish courts have jurisdiction over setting-aside and recognition/enforcement proceedings.

Gün + Partners
15.06.2023

The Protection of European Patents in Turkey and the Compensation of Damages

The Regulation on the Grant of European Patents in Turkey stipulates that a European patent application in which Turkey is designated is considered a national Turkish patent application upon receiving an application number from the EPO. However, there is no requirement in Turkish IP law to publish the European patent application while pending. To claim compensation for patent infringement, the Turkish translation of the claims must be published or the alleged infringing party must be notified. The statute of limitations for filing a compensation action is two years from the date of learning about the damage caused by infringement. Publishing the translation promptly is crucial to protect rights and claim damages.

Gün + Partners
13.06.2023

Corporate Governance in Turkey 2023 - 3

The size of the board of directors is determined by the company's articles of association or the general assembly. There are no minimum or maximum seat requirements. Vacancies on the board can be filled by appointment of the board or approval of the general assembly. There are no specific criteria for directors, but at least one board member must be a woman in listed companies. Disclosure requirements regarding board composition exist. The CEO and board chair positions can be held by the same person, but their duties must be clearly distinguished. Mandatory board committees include an audit committee, corporate governance committee, risk committee, nomination committee, and price committee. Companies must hold regular board meetings, but no minimum number is required. Board practices, evaluations, and remuneration must be disclosed. Remuneration of directors and senior management is determined by the company and disclosed publicly. Shareholders have a vote on remuneration, and companies may provide directors' liability insurance. The corporate charter and by-laws are publicly available. Companies must disclose information regularly and engage with shareholders during general assembly meetings. Disclosure of corporate social responsibility and CEO pay ratio is required.

Gün + Partners
06.06.2023

Corporate Governance in Turkey 2023 - 2

Controlling shareholders in Turkish law do not have specific duties to the company or non-controlling shareholders, but they must exercise their rights in good faith. Special provisions exist for minority shareholders, and the dominant company cannot cause financial loss to its subsidiary without compensation. Shareholders' liability is generally limited to their subscribed capital, except for limited liability companies' government debts. Employees have no specific duty in corporate governance unless assigned as commercial representatives. Share transfer restrictions are allowed under certain circumstances. New shares require shareholder approval, and pre-emptive rights exist. Compulsory share repurchases are allowed in exceptional cases. Share transfer restrictions are prohibited for public companies. Directors owe legal duties to the company, shareholders, and creditors, and enforcement actions can be brought against them. Directors must act with care and in compliance with good faith.

Gün + Partners
05.06.2023

Türk Marka Hukuku’nda Müktesep Hak Kavramı ve Uygulamasına Bir Eleştiri

Türk Marka Hukukunda müktesep hak uygulaması Yargıtayımızın içtihatları ile belirlediği ilkeler çerçevesinde şekillenmiştir. Müktesep hak ilkesi gereğince, bazı istisnai durum ve koşullarda bir işletmeye ait önceki marka, bu işletmenin daha sonraki marka başvuruları için kazanılmış hak teşkil eder. Yargıtay içtihatları çerçevesinde müktesep hak ilkesinin uygulanması için önceki tarihli marka ile sonraki tarihli markaların benzer olması, markaların kapsadıkları mal/hizmet sınıflarının aynı olması ve önceki tarihli markanın çekişme konusu olmaktan çıkmış olması ilkelerinin kümülatif olarak sağlanmış olması gerekmektedir

Gün + Partners
31.05.2023

Corporate Governance in Turkey 2023 - 1

Corporate governance in Turkey is governed by the Turkish Commercial Code (TCC) and other related laws, such as Law No. 6335 and the Capital Markets Law. Listed companies are required to comply with mandatory corporate governance principles, with some exceptions for certain corporations. The Ministry of Trade enforces these provisions, and disputes are resolved in commercial courts. Shareholder rights are protected, allowing them to appoint or remove directors, request extraordinary general assemblies, and demand information.

Gün + Partners
31.05.2023

Sosyal Güvenlik Kurumu Alternatif Geri Ödeme Yönetmeliği Yayınlandı

Alternatif Geri Ödeme Yönetmeliği ile ilgili olarak yapılan yeni düzenlemeler, Yönetmeliğin 2016'daki hükümlerine benzerlik göstermektedir. Öne çıkan değişiklikler şunlardır: Alternatif geri ödeme modellerinin tanımında, yurtdışından temin edilen ürünlerin yerli üretime geçmesi veya piyasada bulunurluğunun sağlanması gibi unsurlara yer verilmemiş, bunun yerine iskonto oranlarının belirlenebileceği ve alım garantisi verilerek sağlık hizmetlerinin ödeme kapsamına alınabileceği belirtilmiştir. Ayrıca Komisyon toplantılarına ilişkin takvim belirlenmiş ve gizlilik hükümleri yeniden yürürlüğe konulmuştur. Yeni düzenlemeler, firmaların ihtiyaçlarına hizmet etmek amacıyla alternatif geri ödeme modellerinin geliştirilmesine odaklanmaktadır. Ruhsat sahiplerinin başvurularını güncellemeleri ve sözleşme süresi biten sağlık hizmeti geri ödemeleri için başvuruda bulunmaları gerekmektedir.

Gün + Partners
24.05.2023

Social Security Institution Alternative Reimbursement Regulation Has Been Published

As a result of lawsuits filed against the provisions of the Alternative Reimbursement Regulation, certain articles were canceled due to a formal deficiency. The new Social Security Institution Alternative Reimbursement Regulation has been published, and notable developments include the explicit definition of alternative reimbursement models and the establishment of a meeting schedule for the Alternative Reimbursement Commission. The regulation also reinstates provisions regarding confidentiality. The new regulation aims to serve the needs of companies by providing predictability and confidentiality in the development of alternative reimbursement models. Marketing authorization holders have been instructed to update their applications, and reimbursement applications must comply with the new regulation.

Gün + Partners
23.05.2023

Yeni Yurt Dışından İlaç Temini Kılavuzu Yayınlandı

Türkiye'de ruhsatı olmayan veya piyasada bulunmayan ilaçlar, hasta talebi ve özel izinle yurt dışından tedarik edilebilir. Yeni Yurt Dışından İlaç Temin Yönetmeliği'ne göre, Yurt Dışından İlaç Temin Kılavuzu güncellenmiştir. Kılavuz, yurt dışı ilaç temin kaynağının kriterlerini ve temsilci yükümlülüklerini belirtir. İlaçlar, yetkili kuruluşlara beşeri tıbbi ürün tedariki yapan yurt dışındaki kuruluşlardan temin edilmelidir. İlaç temin kaynağı, üretici/ruhsat sahibi, yetkili ilaç otoriteleri tarafından ruhsatlandırılmış ecza deposu veya lisans verilen firma olmalıdır. Temsilci, yazılı olarak yetkilendirilmiş yerli bir kişi veya kuruluş olmalıdır. Kaynak ve temsilcinin yükümlülükleri Kılavuzda ayrıntılı olarak belirtilmiştir. Yönetmelik ve Kılavuz, ilaç temini sürecini düzenlemekte olup mali yükümlülükler anlaşmaya bağlıdır.

Gün + Partners
18.05.2023

New Guidelines on Named Patient Program was Published

The Regulation on Supply of Pharmaceuticals from Abroad, recently published in Turkey, introduces new rules for procuring pharmaceuticals not authorized or available in the domestic market. The Guidelines accompanying the Regulation have been updated to reflect these changes. The Guidelines outline criteria for foreign pharmaceutical supply sources, specifying requirements for manufacturers/license holders, pharmaceutical warehouses, and authorized companies. The Regulation emphasizes obtaining products directly from authorized sources and ensuring quality and safety. The Guidelines also address the obligations of the representative appointed by the foreign pharmaceutical supply source, including pharmacovigilance and encoding processes. The Guidelines provide further details and examples not fully covered in the Regulation. The named patient program aims to charge costs to foreign companies, but it could be argued that the state should cover these expenses as part of its responsibility to provide healthcare services to citizens.

Gün + Partners
18.05.2023

Gıda ve Takviye Edici Gıdalarda Sağlık Beyanı ve Beslenme Beyanlarına İlişkin Yeni Düzenlemeler

"Gıda ve Takviye Edici Gıdalarda Sağlık Beyanı Kullanımı Hakkında Yönetmelik" Resmi Gazete'de yayımlanarak yürürlüğe girdi. Türk Gıda Kodeksi Beslenme Beyanları Yönetmeliği ile birlikte yürürlüğe giren yönetmelik, beslenme ve sağlık beyanları için önceki izin ve onay sürecini tamamen kaldırdı. Sağlık Bakanlığı Türkiye İlaç ve Tıbbi Cihaz Kurumu tarafından hazırlanan kılavuzda, gıda ve takviye edici gıdalarda kullanılabilecek sağlık beyanları ve kurallar ayrıntılı olarak yer alıyor. Kayıtlı veya onaylı işletmeler tarafından üretilen veya ithal edilen ürünler, yönetmelik ve kılavuz hükümlerine uygunsa izin başvurusu yapmadan sağlık beyanları kullanılabilecek. Kurum, kamu sağlığı açısından gerekli gördüğü durumlarda sağlık beyanı kullanımını sınırlayabilir ve denetim mekanizmalarını işletebilir.

Gün + Partners
13.05.2023

New Regulations on Nutrition and Health Claims for Food and Food Supplements

Turkey's Regulation on Health Claims for Food and Food Supplements has come into force, alongside the Turkish Food Codex Regulation on Nutrition Claims, repealing the previous Turkish Food Codex Regulation on Nutrition and Health Claims. The new regulations abolish the permission requirement for competent administrative authorities before making health claims for food and food supplements, introducing fundamental changes. A Guideline for Health Claims for Food and Food Supplements has been drafted by the Ministry of Health Turkish Pharmaceuticals and Medical Devices Authority, listing permitted health claims and detailed provisions. Health claims can be used without official permission, subject to certain conditions, and the Authority may limit their use to protect public health.

Gün + Partners
10.05.2023

Turkish MDR and IVDR Amended

On 2 April 2023,  regulations amending the Turkish Medical Device Regulation (Turkish language) and the Turkish In Vitro Medical Device Regulation (Turkish language) were published in the Official Gazette numbered 32151.  They amend he transitional provisions stipulated in the which was published in the Official Gazette numbered 31499 to be in line with the transitional provisions applicable to  Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR).

Gün + Partners
04.05.2023

Communiqué on Electronic Instructions for Use of Medical Devices Published (Turkey)

On 6 April 2023, the Turkish Medicines and Medical Devices Agency published a new Communiqué on Electronic Instructions for Use of Medical Devices (Turkish language) in the Official Gazette numbered 32155.

Gün + Partners
28.04.2023

Decision on Pricing of Human Medicinal Products Amended with New Price Calculation

On 14 March 2023, the Presidential Decree numbered 6932 Amending the Decision on Pricing of Medicinal Products for Human Use was published in the Official Gazette numbered 32132.

Gün + Partners
26.04.2023

A Precedent on 3D Trademarks’ Enforcement

In 2022, the Turkish Court of Cassation rendered a decision evaluating that the use of a 3D trademark as bag-locks on counterfeit goods infringed the trademark holder’s rights and the accused should have known that this 3D shape is a trademark.

Gün + Partners
24.04.2023

Amendments to the Execution and Bankruptcy Law and Certain Laws

The Law Amending the Enforcement and Bankruptcy Law and Certain Laws, known as the 7th Judicial Package, was published in the Official Gazette (32154) dated 05 April 2023 and entered into force except for several provisions with later effective dates.

Gün + Partners
20.04.2023

Recent Developments in TURKPATENT's Practice on Recording of Well-known Trademarks

We have previously reported on the Turkish Court of Cassation’s decision concluding that the Turkish Patent and Trademark Office has no authority to create and maintain a registry for well-known trademarks and discussed possible repercussions of this decision for trademark owners.

Gün + Partners
17.04.2023

Legislative Proposal on the Amendment of the Law on Pharmaceuticals and Medical Preparations No. 1262 and Certain Laws

The Legislative Proposal on the Amendment of the Law on Pharmaceuticals and Medical Preparations No. 1262, Certain Laws and Decree Law No. 663 dated March 20, 2023, and numbered 2/5006 is an omnibus bill having some amendment offers regarding the regulating legislation of the health sector.

Gün + Partners
15.04.2023

What’s New In The Amended E-Commerce Law For IP

Law No. 7416, amending E-Commerce Law, came into effect on 1 January 2023, and a comprehensive change has been made to Article 9, titled "obligations of intermediary service providers", including the title of the provision.

Gün + Partners
13.04.2023

Can The Accused be Acquitted Solely on The Grounds That The Number of Seized Counterfeits Is Very Low?

The acts considered as infringement of trademark rights are regulated under Article 29 of Industrial Property Law no. 6769 and article 29/1(c) states that “To imitate the trademark upon using the trademark or its indistinguishably similar version without the permission of the holder; to sell, distribute, to trade in any other way, to import, export, keep for commercial purposes the products bearing the trademark used by means of violation…” constitute trademark infringement.

Gün + Partners
11.04.2023

Is Partial Victory a Real Victory?

In 2022, the Ankara Regional Court of Appeal rendered a decision for an appeal regarding a cancellation action against the Turkish Patent and Trademark Office’s decision.

Gün + Partners
11.04.2023

The Revocation Procedure of Trademarks to be Handled by the Turkish Patent and Trademark Office

Until the Industrial Property Law No. 6769 entered into force on January 10, 2017, procedures regarding trademark rights were carried out with the abolished Decree-Law No. 556 on the Protection of Trademarks.

Gün + Partners
10.04.2023

Advertisements Required to Include +18 Markings

The Advertisement Board rendered a highly controversial decision in July 2022 concluding that the promotions published by a fashion company on the main page of its website under the title of “My Chosen Family” including the following statements “My Chosen Family: A chosen family consists of members who chose to support and love each other.

Gün + Partners
07.04.2023

Turkish Court of Cassation Rules in CERAN v CERAMO Case

In a recent case, the General Assembly of Civil Chambers of the Turkish Court of Cassation ruled that although the defendant argued that the earlier trade mark CERAN originates from the word “ceramic”, this is not the case and CERAN functions as a trade mark for Turkish consumers.

Gün + Partners
06.04.2023

Implementation of Guideline on Social Media Influencers

Social media advertising is mainly regulated under Consumer Protection Law and the Advertising Regulation in Turkey. In 2021, the Advertisement Board drafted Guideline on Commercial Advertisement and Unfair Commercial Practices Conducted by Social Media Influencers”, which was prepared based on the Consumer Protection Law to serve as a basis for examinations of commercial advertisements and unfair commercial practices run by Social Media Influencers.

Gün + Partners
05.04.2023

Unified Patent Court - How It Will Resonate in Turkey?

The concept of the Unified Patent Court entered the lives of European Patent holders with the UPC Agreement, an international agreement dated February 19, 2013.

Gün + Partners
04.04.2023

Social Responsibility Awareness and Social Values in Advertisements

The Advertisement Board rendered a guiding decision in September 2022 with respect to the advertisements published by an international fashion company operating in Turkey as well in which some food products particularly like bread and doughnuts covered with colourful toppings were placed together with some attractive shoes and sandals offered for sale.

Gün + Partners
04.04.2023

Conformity of Comparative Advertisements to the Advertising Law

Pursuant to the Advertising Regulation, direct comparative advertising practice is considered unlawful as it is prohibited thereunder to mention the product name, trademark, logo, trade name, business name or other distinctive features of competitors in advertisements.

Gün + Partners
03.04.2023

Advertisements Containing Environmental Claims

Until recently, there was no regulation specifically applicable for advertisements containing environmental claims. Absent a specific regulation, the Advertisement Board used to conduct its evaluation on such advertisements pursuant to the provisions included in the Advertising Regulation which states that advertisements must not abuse consumers’ environmental sensitivity or lack of knowledge in this field.

Gün + Partners
01.04.2023

Advertisements Containing Price Information and Discount Sales Advertisements

Advertising Regulation was amended in a way to include new measures and rules to regulate advertisements containing misleading price information and to protect consumers against unfair commercial practices.

Gün + Partners
28.03.2023

Regulations on Consumer Reviews and Complaints

Specific rules for consumer reviews and publishing consumer complaints were introduced into Turkish law by amendments made to the Advertising Regulation effective as of March 2022.

Gün + Partners
27.03.2023

Advertisement Board’s Expanded Power: Blocking Access

The traditional sanctions that the Advertisement Board used to apply were ordering administrative fine, correction decision and precautionary or temporary suspension decisions against advertisements which violate the legal rules for advertisements broadcasted in any media including internet.

Gün + Partners
24.03.2023

Court of Cassation Overturns Longstanding Precedents on Cumulative Protection Afforded by Trademark Infringement and Unfair Competition Provisions

In a recent decision that challenges longstanding precedents, the Court of Cassation has ruled that, in cases where trademark infringement has been found, it is no longer possible to accept that the same infringing act also creates unfair competition.

Gün + Partners
22.03.2023

Pricing of Pharmaceuticals and the Fixed Exchange Rate - 2023

Pharmaceutical prices in Turkey have always been one of the most controversial issues. The prices of medicines that are to be marketed are set under the Decision on Pricing of Human Medicinal Products and the Communiqué on the Pricing of Human Medicinal Products of September 29, 2017, issued by the Ministry, which is vested with the competencies to regulate this area.

Gün + Partners
20.03.2023

“Plausibility” in Turkish Patent Law and Its Impact on Invalidation Proceedings

The concept of plausibility – which has been the subject of numerous evaluations, especially by the European Patent Office (“EPO”) and frequently debated in academic circles in recent years – has not yet found a place within the scope of any legal regulation in Turkey.

Gün + Partners
17.03.2023

Market Access - Alternative Reimbursement Models - 2023

For an extended period, the pharmaceutical industry needed a unique model of reimbursement where its conditions could be set together through negotiation with the SSI, and the regular price and reimbursement rules did not apply to innovative products.

Gün + Partners
16.03.2023

The Need for an Injunction in Cases Where the EPO Proceeding is held as a Pending Issue

Although there is no explicit provision in Turkish Law for the acceptance of the ongoing opposition or appeal proceedings before the European Patent Office as a “pending issue” due to the principle of procedural economy, in practice, pending issue decisions may be given by the Civil Courts of Intellectual and Industrial Property Rights according to the particular circumstances.

Gün + Partners
16.03.2023

Preliminary Injunction Decisions against Patent Trolls to Prevent the Enforcement of Patent Rights

The patent and utility model rights, the backbone of incentivizing R&D and innovation, provide their holders with a significant advantage over their competitors and grant an absolute right for a certain period.

Gün + Partners
13.03.2023

Named Patient Program - 2023

Named Patient Programs is one of the exceptional importation regimes of pharmaceuticals without marketing authorization in Turkey or with marketing authorization, but which are unavailable in the Turkish market for various reasons.

Gün + Partners
10.03.2023

Current Practice of Bolar Exemption in Turkish Patent Law

Article 85(3)/(c) of the Industrial Property Law No. 6769 regulates the Bolar Exemption, which stipulates the exclusion of experimental acts containing the invention subject to the patent from the scope of the patent right, including the licensing of pharmaceuticals and the necessary tests and experiments thereof.

Gün + Partners
10.03.2023

Developments in the field of Medical Devices

After the long-awaited Regulation on Medical Devices numbered 2017/745, prepared by the EU Commission, has entered into force, Medical Device Regulation, which was designed following MDR, was published in the Official Gazette numbered 31499 on June 2, 2020.

Gün + Partners
08.03.2023

SEP: Navigating the Technology-Driven World

Standard-Essential Patents are the concept arising from the interaction between patent rights, which provide exclusive use of an invention and “standards” aimed at the widespread and mandatory use of this innovation in the relevant market.

Gün + Partners
07.03.2023

Food Supplements, Food for Special Medical Purposes and Other Products

The Regulation on the Importation, Production, Processing and Supply of Food Supplements was published by the Ministry of Food and Forestry on May 2, 2013, in the Official Gazette and came into force on August 2, 2013.

Gün + Partners
07.03.2023

Regional Court of Appeals: The Decision of the TMMDA of Refusal of the Applications of the Original Medicine Owners to Obtain Information on Reference Product is Unlawful

As per article 9 of the Regulation on Authorization, which regulates “Abridged Application”, if a pharmaceutical has been authorized before, it is not necessary to repeat the tests and research, and the data of these tests doesn’t have to be submitted for authorizing again, …

Gün + Partners
03.03.2023

Development of Telemedicine Activities in Turkey

Telemedicine is one of the areas that are not explicitly regulated under Turkish law. Within the scope of the existing legal framework, the Medical Deontology By-law and Ethical Principles for Physicians prohibit remote examination, diagnosis, and treatment of patients.

Gün + Partners
02.03.2023

Covid Sonrası Dönemde Fikri Mülkiyet Haklarından Feragat

Pandeminin etkisinin azalmaya başladığı ve hayatın yavaş yavaş normal seyrine döndüğü bugünler, Covid-19 pandemisinden çıkarılabilecek derslere bakmak ve olası yeni bir pandemiye karşı gerekli hazırlıkları yapmak için iyi bir dönem.

Gün + Partners
02.03.2023

Waiving from IP Rights in the Post-Covid Landscape

Since the pandemic seems to lose its impact and life is returning to normal, it may be a good time to look into the lessons learned so far from the Covid-19 pandemic and make necessary preparations against a possible new one.

Gün + Partners
01.03.2023

Litigation and Enforcement 2023 in Turkey - 2

A party must disclose all evidence that it intends to rely on. A party is not required to disclose all relevant documents in its possession but must only provide documents that it deems appropriate. Parties must act in good faith and state the truth (Article 29, CPC).

Gün + Partners
01.03.2023

Litigation and Enforcement 2023 in Turkey - 1

The main and most commonly used method for resolving large commercial disputes in Turkey is litigation. Civil litigation is based on the principle that the parties to the dispute prepare their case. The judge is bound to hear claims, defences and evidence brought by the parties.

Gün + Partners
01.03.2023

Haklı Sebeple Fesih Davaları

Ortaklarının sınırlı sorumlu olmasından dolayı en çok tercih edilen ortaklık türlerinden biri olan anonim şirketlerde ailevi ve kişisel konuların yanı sıra şirketlerin performansında beklentilerin karşılanmaması gibi pek çok sorun, bazı ortakların ortaklıktan çıkma taleplerini beraberinde getiriyor.

Gün + Partners
27.02.2023

Türkiye’de Patent Hukuku Alanında Önemli Gelişmeler ve Öngörüler

Sınai Mülkiyet Kanunu'nun getirdiği yenilliklere ve uygulamada doğurduğu zorluklara büyük ölçüde uyum sağlandıktan sonra, Türk patent sistemi bu defa da pandemi sonrası meydana gelen birtakım değişikliklere adapte olma sürecine girmiş bulunuyor.

Gün + Partners
24.02.2023

Key Developments and Predictions for Patent Law in Turkey

After adapting to the innovations brought by the Intellectual Property Law and the difficulties, it has brought into practice, this time the Turkish patent system has entered the process of adapting to the changes that have occurred after the pandemic.

Gün + Partners
24.02.2023

Çevre Dostu Ürünler, Yeşil Reklamlar!

Son zamanlarda sık sık reklamlarda, tanıtımı yapılan ürünlerin veya hizmetlerin “eko”, “çevre dostu”, “doğa dostu” “yeşil” ve “geri dönüştürülebilir” olduğu konusunda reklam veren şirket tarafından ikna edilmeye mi çalışılıyorsunuz? Bir ürünün çevre dostu olması, ürünü satın alma ve kullanma tercihlerinizde etkili oluyor mu? Artık aslında yeterince “yeşil” olmayan ancak “yeşil” olduğu belirtilen ürünlere ilişkin reklamlara ayrılan sürenin sonuna mı geldik?

Gün + Partners
23.02.2023

Eco-Friendly Advertisements!

When you watch the commercials, do you often feel like advertising companies are working hard to convince you that their products or services are “eco”, “environmentally friendly”, “nature friendly”, “green” and “recyclable”? Does environmentally-friendly feature of a product have any impact on your preference to purchase or use it? In fact, are we yet at the end of an era of advertising products that are not “green” enough but promoted to be “green”?

Gün + Partners
22.02.2023

Ticaret Siciline Tescil Edilen İşlemler için Vergi Dairesi Bildirim Zorunluluğu Kaldırıldı

Ticaret siciline tescil edilen işlemlerden Ticaret Bakanlığı tarafından elektronik ortamda Hazine ve Maliye Bakanlığı’na (“Bakanlık”) yapılan bildirimlerin mükellefler tarafından yapılmış bildirim olarak kabul edilmesine ilişkin usul ve esasların belirlendiği, 546 Sıra No’lu Vergi Usul Kanunu Genel Tebliği (“Tebliğ”), 1 Şubat 2023 tarihinden itibaren yürürlüğe girmek üzere, 18 Ocak 2023 tarihli Resmi Gazete’de yayımlanmıştır.

Gün + Partners
21.02.2023

Yurt Dışından İlaç Temini Yeni Yönetmelik ile Düzenlendi

Türkiye’de ruhsatlandırılmamış veya ruhsatlı olmakla birlikte piyasada bulunmayan ilaçlara hastaların ihtiyaç duyduğu durumlarda; söz konusu ilaç, hekimlerin talebi ve özel izinle yurt dışından tedarik edilebilmektedir. İlaçlar için öngörülen bu istisnai ithalat rejimi, yakın bir zamana kadar Türkiye İlaç ve Tıbbi Cihaz Kurumu (“TİTCK”) tarafından yayınlanmış olan Yurt Dışından İlaç Temini Kılavuzu ile düzenlenmekteydi. 3 Şubat 2023 tarihli 32093 sayılı Resmî Gazete’de Yurt Dışından İlaç Temin Yönetmeliği (“Yönetmelik”) yayınlanarak eski kılavuz yürürlükten kaldırılmıştır.

Gün + Partners
21.02.2023

Arbitration Procedures and Practice 2023 in Turkey - 2

Both the International Arbitration Code and Civil Procedural Code contain default procedural rules. However, the majority of these rules are not mandatory, and the parties are free to determine procedural rules in their arbitration agreement or after the arbitration begins. In practice, the parties often agree to apply institutional arbitration rules with their sets of default procedural rules.

Gün + Partners
21.02.2023

Arbitration Procedures and Practice 2023 in Turkey - 1

In Turkey, arbitration traditionally evolved as a dispute resolution mechanism, which was used more frequently in large commercial disputes where a foreign party is involved and mostly when a legal counsel is involved in the preparation of the principal contract between the parties. For all other matters, particularly concerning disputes of smaller value, Turkish parties tended to grant jurisdiction to the Turkish courts.

Gün + Partners
21.02.2023

Notification Obligation to Tax Office for Registered Transactions in the Trade Registry is Abolished

The General Communiqué no. 546 on Tax Procedural Law (the "Communiqué") which determines the procedures and principles regarding the acceptance of the notifications made electronically by the Ministry of Trade to the Ministry of Treasury and Finance (the "Ministry") from the transactions registered in the trade registry as notifications made by taxpayers was published in the Official Gazette dated 18 January 2023, to be effective as of 1 February 2023.

Gün + Partners
21.02.2023

New Regulation on Named Patient Programs is Published

Pharmaceuticals that are not authorized in Turkey and/or not available in the market despite being authorized, shall be procured from abroad upon request of physicians and special authorization in cases where patients require such pharmaceuticals. Until recently, this exceptional import regime for pharmaceuticals was regulated by the Guideline on the Supply of Pharmaceuticals from Abroad published by the Turkish Medicines and Medical Devices Agency ("Agency").

Gün + Partners
21.02.2023

Implementation of the Limitation of Goods and Services by the Turkish Patent and Trademark Office

The Turkish Patent and Trademark Office (TPTO) allows international trademark applications filed via WIPO to limit the classes of goods/services, but does not grant the same opportunity for national trademark applications. This controversial approach prevents applicants from avoiding potential disputes and contradicts the obligation of mediation in civil and criminal actions, as well as Article 19/4 of the IP Code. The disparity between national and international applications undermines the basic principles of private law and could be resolved by broadening the interpretation of limitation requests.

Gün + Partners
02.02.2023

Proof of Bad Faith: The Turkish Court of Cassation Adopts a Surprising Stance

The Turkish Court of Cassation reversed a lower court's decision to invalidate a trademark registration due to bad faith, narrowing the application of the bad faith argument under Article 6/9 of the Turkish IP Code. The court ruled that similarity or identity of trademarks alone is insufficient evidence of bad faith and must be supported by additional factors, such as a past relationship between the parties. The decision contradicts some previous rulings that found applicants imitating well-known trademarks were acting in bad faith, and raises concerns about the potential impact on future intellectual property cases in Turkey.

Gün + Partners
02.02.2023

Corporate Governance and Directors Duties in Turkey Overview - 3

The Q&A gives a high-level overview of corporate governance trends; the main forms of corporate entity used; the corporate governance legal framework; corporate social responsibility and reporting; board composition and restrictions; directors' remuneration; management rules and authority; directors' duties and liabilities; transactions with directors and conflicts; disclosure of information; shareholders' rights, company meetings, and minority shareholder action; and internal controls, accounts and audits.

Gün + Partners
31.01.2023

Corporate Governance and Directors Duties in Turkey Overview - 2

The Q&A gives a high-level overview of corporate governance trends; the main forms of corporate entity used; the corporate governance legal framework; corporate social responsibility and reporting; board composition and restrictions; directors' remuneration; management rules and authority; directors' duties and liabilities; transactions with directors and conflicts; disclosure of information; shareholders' rights, company meetings, and minority shareholder action; and internal controls, accounts and audits.

Gün + Partners
31.01.2023

Corporate Governance and Directors Duties in Turkey Overview - 1

The Q&A gives a high-level overview of corporate governance trends; the main forms of corporate entity used; the corporate governance legal framework; corporate social responsibility and reporting; board composition and restrictions; directors' remuneration; management rules and authority; directors' duties and liabilities; transactions with directors and conflicts; disclosure of information; shareholders' rights, company meetings, and minority shareholder action; and internal controls, accounts and audits

Gün + Partners
31.01.2023

DELPHI v DEPLHI: PTO’s Decision Sheds Light on Interpretation of Bad Faith

Delphi Technologies IP Limited opposed the registration of the DEPLHI trademark in Classes 1, 3, and 4, citing similarities to its earlier mark DELPHI used in the automotive spare parts sector. The Turkish Patent and Trademark Office initially rejected the opposition but the Re-examination and Evaluation Board later accepted it, finding that the trademarks were similar and covered similar goods and services. The board also concluded that the DEPLHI application was filed in bad faith given the distinctiveness and reputation of the DELPHI mark in the sector. The decision demonstrates the importance of considering all relevant factors in assessing bad faith in trademark disputes.

Gün + Partners
30.01.2023

Çevreye İlişkin Beyanlar İçeren Reklamlar Hakkında Kılavuz Yayınlandı

Reklam Kurulu'nun 13.12.2022 tarihli toplantısında kabul edilen "Çevreye İlişkin Beyanlar İçeren Reklamlar Hakkında Kılavuz" yayınlandı. Bu kılavuz, ticari reklam ve uygulamalarda yer alan çevresel beyan ve görsellerin ilgili mevzuata uyumlu olmalarını sağlamak için hazırlandı. Kılavuz, çevresel beyanların hangi bilgilere yer vermesi gerektiği konusunda ayrıntılı açıklamalar içeriyor. Reklamlarda belirtilen çevresel beyanların hangi bölümlere veya süreçlere ilişkin olduğu açıkça belirtilmelidir. Çevre kirliliği veya atık birikmesine yol açabilecek tüketici davranışlarını özendiren reklamlardan kaçınılmalıdır. Bu kılavuzun reklamcılık alanında birçok karara yol göstereceği düşünülmektedir. Kılavuza Reklam Kurulu'nun resmi internet sitesinden ulaşılabilir.

Gün + Partners
28.01.2023

Countdown to Revocation Requests at the TPTO

Turkey's Patent and Trademark Office (TPTO) will enable trade mark revocation proceedings from 10 January 2024. The Intellectual Property Code no. 6769 entered into force on 10 January 2017, including Article 26, which regulates trade mark revocation. The clause was due to be introduced seven years later, allowing the TPTO to start making preparations for the change. While the change is expected to streamline the process and make it more cost-effective, some have raised concerns about the finalisation of proceedings and the evaluation of use evidence. The TPTO has started preparations for the implementation of the new practice.

Gün + Partners
27.01.2023

Determination of Evidence in Disputes Over Pharmaceutical Patents

The determination of evidence is a crucial interim legal protection measure in Turkish law that assists in proving the matter in question. In disputes relating to pharmaceutical patents, the determination of evidence is a prerequisite to benefit from a preliminary injunction. Under the Industrial Property Law No. 6769, judicial authorities can order immediate and effective interim measures to protect evidence related to an alleged infringement. However, access to information is limited for drug patent holders, making it difficult to obtain proof to prove preliminary injunction conditions have been met. Therefore, a court-ordered evidence determination decision is necessary for drug patent holders to benefit from the preliminary injunction institution.

Gün + Partners
24.01.2023

Lack of Regulation on Plausibility Attacks in Turkish Patent Law

The plausibility concept in patent law is not yet regulated in Turkish legislation, and there is no consensus on the Turkish word that corresponds to this legal term. However, plaintiffs have started to argue the requirement of plausibility in Turkish invalidity proceedings. The issue of plausibility is particularly important with regard to pharmaceutical patents, as all clinical studies' test data may not be obtained by the patent application's date. Therefore, it is still a subject of debate how much research should be included in the patent application and to what extent post-published evidence can be used. The EPO Enlarged Board of Appeal's G 2/21 decision may bring about important standards regarding plausibility, which will affect Turkish patent law.

Gün + Partners
11.01.2023

Protection of Websites Under Turkish Law

The legal protection of websites in Turkey is a complex issue that requires practitioners to be aware of all possible legal remedies and the possibilities of infringement. Although there is no straightforward regulation to confer legal protection to websites under Turkish law, courts consider the specific circumstances of each case and assess the limit of the allowed use. The stronger the originality of the website, the stronger the legal protection would be. To protect their websites, owners should register trademarks, establish comprehensive contracts with independent contractors, monitor the market for potential infringement, and ensure the security of their intellectual property.

Gün + Partners
03.01.2023

Authorization Obligation is on the Horizon for OTT Services

Turkey's "disinformation law" has come into force, making all over-the-network (OTT) service providers subject to regulations that include an authorisation obligation. Under the law, OTT service providers must apply to the Information and Communication Technologies Authority (BTK) for authorisation through a fully authorised representative, which must be a joint stock company or limited liability company in Turkey. Other regulations that may apply include obligations on consumer rights, personal data protection and service quality, as well as reporting and financial obligations. Fines for non-compliance range from TRY 1m to TRY 30m, and non-payment could lead to bandwidth reduction or blocking of access to the relevant application or website.

Gün + Partners
28.12.2022

The Euro Value Applied to Pharmaceutical Prices was increased by 36.77%

On December 14, 2022, the Turkish presidential decree numbered 6546 was published in the Official Gazette, amending the Decision on Pricing of Medicinal Products for Human Use, which increases the value of 1 Euro in Turkish lira by 36.77% in December 2022. As a result, the price scales stipulated in the Decision were updated, and the threshold value for price-protected products has been determined as TRY 37.10 while it has been determined as TRY 19.39 for other products in line with the change in the exchange rate. This is the third time this year the exchange rate has been updated, and the amendment also indicates that there will be no revaluation in 2023.

Gün + Partners
28.12.2022

Court Provides Guidance on How to Conclude Actions For Undue Receivables

The Grand General Assembly on the Unification of Judgments of the Court of Cassation in Turkey recently ruled that actions initiated for undue receivables should be dismissed on procedural grounds, as the plaintiffs lack legal interest as a cause of action. This unification decision resolves a controversy in Turkish law, where courts had been divided on whether to examine such cases on their merits or dismiss them on procedural grounds. The decision also clarifies the applicable attorney fees, eliminating unfair practices resulting from the previous inconsistency in judgments.

Gün + Partners
18.12.2022

Extension of the Deadline Regarding Amendments to the Communiqué With Respect to Capital Loss and Negative Equity

The Amending Communiqué, published on November 8, 2022, extends the deadline under Provisional Article 1 of the Implementation Communiqué for Turkish Commercial Code No. 6101. The deadline to exclude certain loss items from capital loss or negative equity calculations is now January 1, 2024. This temporary measure helps protect economic actors from the impact of the Covid-19 pandemic. Eligible companies can exclude all foreign exchange losses and half of specific expenses from capital loss and negative equity calculations until the end of the fiscal year 2023.

Gün + Partners
18.12.2022

Recent Changes in Relation to Determination of Companies Subject to Independent Auditing

Presidential Decision No. 6434 introduces significant changes to independent auditing thresholds for Turkish companies, effective from January 1, 2023. The updated criteria raise financial limits, which could reduce the number of companies requiring independent auditing, but also make employee number conditions more inclusive for certain companies. The decision impacts publicly-traded companies, Annex-II companies, and those listed in Annex-I, including financial institutions and media service providers. Companies should closely monitor the new thresholds to ensure compliance with independent auditing requirements.

Gün + Partners
18.12.2022

Sanction Against Shoe Ad Disrespecting Food

The Advertisement Board's recent decision on an international fashion company's ad highlights the importance of respecting cultural values and social responsibility in advertising practices. The ruling, based on Article 7/2 of the Regulation on Commercial Advertisement and Unfair Commerce Practices, states that the company's use of food products alongside footwear disrespects food and violates the principles of fair competition. This decision sets a significant precedent for interpreting the sense of economic and social responsibility in advertisements.

Gün + Partners
18.12.2022

Life Sciences 2023 in Turkey

Turkey's healthcare system is primarily governed by the Fundamental Law on Healthcare Services No. 3359, which empowers the Ministry of Health (MoH) to issue regulations and establish a system with equal and equitable access. Hospitals and public health institutions are regulated and established by the MoH and its subsidiaries. The Social Security Institution provides insurance, while public, private, and training and research hospitals provide healthcare. Healthcare product licensing, pricing, and distribution are managed by the Turkish Medicines and Medical Devices Agency. E-Nabız, the MoH's encrypted personal health record system, was launched in 2015. Healthcare data is protected by Data Protection Law No. 6698 and Personal Health Data Regulation No. 30808.

Gün + Partners
02.12.2022

Guidelines on Donation of Non-Approved Drugs

On September 28, 2022, the Turkish Medicines and Medical Devices Agency published guidelines outlining the procedures and principles for donations of human medicinal products not approved in Turkey. Donations must align with the World Health Organization's medicine donation guidelines and be evaluated by the Ministry of Health based on their list of required medicines. In exceptional cases, the Agency may accept donations on a patient basis for medicines without a compassionate use program. The guidelines also detail customs clearance, storage, distribution, and delivery rules for donated medicines. The guidelines came into effect upon publication.

Gün + Partners
02.12.2022

The Danger of De Facto Abolishment of the Right to Preliminary Injunction by the Determination of Evidence in Terms of Pharmaceutical Patents

Temporary legal protection in pharmaceutical patent disputes relies on evidence determination to prove a case. Drug patent holders must get a preliminary injunction to keep infringing products off the market because patent rights are limited. Without a court order, infringing drug information is difficult to obtain. Patent holders must establish evidence under Article 400 of the Code of Civil Procedure and Article 150/3 of the Industrial Property Law to obtain a preliminary injunction. Different court evidence determination methods can affect pharmaceutical patent disputes.

Gün + Partners
02.12.2022

New Provision Introduced to Decision on Drug Pricing

On November 9, 2022, Presidential Decree 6365 amended the Decree on Pricing of Medicinal Products for Human Use in Turkey. The amendment excludes temporary price changes, product classification, and taxation practices from the real source price calculation. Additionally, products sold exclusively for hospital use will not be considered when calculating retail prices. The new clause is effective as of its publication date.

Gün + Partners
02.12.2022

Promotion at Gün + Partners

As a full-service law firm based in Istanbul providing transactional, advisory, and dispute management services to local and international companies throughout Turkey and assisting clients worldwide through its established network of correspondents and contacts Gün + Partners has int...

01.03.2023

Gün + Partners Seeks Mid-level / Senior Associate for Commercial Litigation & Dispute Resolution Department

No longer accepting applications.Gün + Partners, founded in 1986, has 13 partners and over 70 lawyers, providing transactional, advisory, and dispute management services to local and international companies throughout Turkey and assisting clients worldwide through its established network of corresp...

18.01.2023

Webinar: CJEU Decision Review - The Concepts of Free-Riding and Bad Faith in Reviving a Priorly Well-Known Trademark in light of the Nehera Decision

Date - TimeThursday, Sep 28, 202317:00 - 18:00 (Local Time in Türkiye)Zoom Webinar ID - 873 1466 1408In the eighth of Gün + Partners' Court of Justice of the European Union (CJEU) decision review webinars, the speakers will discuss the CJEU's "Nehera decision".The webinar will be open to gene...

05.09.2023

Webinar: World IP Day – Conversation on Women and IP: Accelerating Innovation and Creativity

Date - TimeThursday, April 27, 20231:30 pm - 2:30 pm (GMT)4:30 pm - 5:30 pm (GMT+3, Istanbul)Gün + Partners will be celebrating the World IP Day with webinars.Please join us for a fireside chat between Mutlu Yıldırım Köse and our guests Prof. Özlem Er and Prof. Şebnem Timur.This webinar conce...

11.04.2023

Webinar: World IP Day - Women and IP: Women Behind Life Changing Innovations - An Interview with Prof. Rana Sanyal

Date - TimeTuesday, April 25, 20231:00 pm - 2:00 pm (GMT)4:00 pm - 5:00 pm (GMT+3, Istanbul)Gün + Partners will celebrate World Intellectual Property Day with webinars.The webinar titled "Women and IP: Women Behind Life-Changing Innovations" will be held by Selin Sinem Erciyas, Partner of Gün + Pa...

24.03.2023

INTA Pre-Annual Meeting Reception 2023

Date - TimeMonday, April 3, 2023, 16:00 - 18:00LocationGün + Partners / Kore Şehitleri Cad. 17 Zincirlikuyu 34394 Istanbul, TurkeyInternational Trademark Association (INTA) and Gün + Partners cordially invite you to attend our in-person Pre-Annual Meeting Reception in Istanbul.The 2023 Internatio...

22.03.2023

Assistant Promotion and Business Development Specialist

We are looking for an Assistant Promotion and Business Development Specialist to work in the Strategy and Business Development Department.Requirements are:- Bachelor's degree from the relevant departments of universities,- Experience of 2-3 years at most,- Motivation and wil...

14.04.2024

Assistant Trademark Attorney

We are looking for an "Assistant Trademark Attorney", to be trained as a "Trademark Attorney" in our registration team, the job description being:Assisting trademark attorneys in all processes of trademark applications from research to registration,Preparing relevant reporting drafts.Requiremen...

26.02.2024

Mid-level/Senior Associate (Commercial Litigation & Dispute Resolution)

For our growing team we accept applications from lawyers with the followings skills and qualifications.Graduate of a reputable Turkish law school, preferably with an LLM degree,Minimum 4-5 years of experience as a qualified lawyer in Commercial Litigation & Dispute Resolution in a reputabl...

05.01.2024
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent